homocysteine has been researched along with Diabetes Mellitus, Type 2 in 338 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 22 (6.51) | 18.2507 |
| 2000's | 174 (51.48) | 29.6817 |
| 2010's | 104 (30.77) | 24.3611 |
| 2020's | 38 (11.24) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, J; Geng, HR; Lin, Y; Liu, L; Qiao, YN; Qu, YY; Xu, W; Zhang, X; Zhao, JY | 1 |
| Chan, P; Fu, JL; Mu, ZJ; Sun, LN; Xiu, SL | 1 |
| Bulum, T; Ljubić, S; Rahelić, D; Tomić, M; Vrabec, R | 1 |
| Ando, K; Fujimoto, K; Hiraishi, C; Kojima, T; Matsui, S; Sato, R; Yoshida, H | 1 |
| Fouad, MM; Helmy, MA; Mahdy-Abdallah, H; Mansour, NAE; Shahy, EM; Taha, MM | 1 |
| Berberoglu, M; Dogan, O; Eminoglu, FT; Kontbay, T; Kose, E; Siklar, Z; Taş, Ö; Tumer, L | 1 |
| Joshi, MB; Mohanty, V; Nair, AS; Najar, MA; Prasad, TSK; Shastry, S; Thimmappa, PY | 1 |
| Cariou, B; Croyal, M; Gand, E; Goronflot, T; Hadjadj, S; Jacobi, D; Le May, C; Prieur, X; Ragot, S; Saulnier, PJ; Trochu, JN; Wargny, M | 1 |
| Cruciani-Guglielmacci, C; Daubigney, F; Denis, RG; Denom, J; Georgiadou, E; Janel, N; Kassis, N; Le Stunff, H; Magnan, C; Makaci, F; Meneyrol, K; Migrenne-Li, S; Paul, JL; Rachdi, L; Rodriguez Sanchez-Archidona, A; Rutter, GA; Thorens, B | 1 |
| Liu, D; Liu, J; Wu, J; Yang, L | 1 |
| Dabees, H; El-Khodary, NM; Werida, RH | 1 |
| Chen, X; Fung, AT; Gong, Z; Nie, Y; Qiu, B; Sivaprasad, S; Wang, Q; Wang, Y; Xie, R; Zhang, X | 1 |
| Fang, ZZ; Gao, XQ; Jiang, CT; Liu, X; Luo, WM; Su, JY; Wang, WY; Zhang, W; Zhang, ZP | 1 |
| Chang, J; Jiang, WC; Li, M; Wu, K | 1 |
| Duan, Q; Jin, J; Li, Y; Wen, S; Zhou, L; Zhou, M | 1 |
| Dong, J; Guo, G; Jin, M; Li, D; Li, X; Nan, J; Zhang, X | 1 |
| Lauren, BC; Pratama, S; Wisnu, W | 1 |
| Chen, K; Chen, W; Jiang, X; Li, D; Liu, C; Lu, J; Ma, Z; Shen, Y; Tian, H | 1 |
| Bakthavatsalam, M; Brelen, ME; Chan, KP; Chan, TI; Chu, KO; Pang, CP; Wang, CC; Yip, YW | 1 |
| Shen, Z; Zhang, Z; Zhao, W | 1 |
| Cheng, W; Guo, J; Huang, AM; Li, H; Liang, J; Liu, C; Liu, Z; Wang, W; Yang, R; Zhang, J | 1 |
| Bastani, NE; Dagnelie, PC; Elshorbagy, AK; Eussen, SJPM; Grootswagers, P; Kožich, V; Olsen, T; Refsum, H; Retterstøl, K; Stehouwer, CD; Stolt, ETK; Tore, EC; van Greevenbroek, MMJ; Vinknes, KJ | 1 |
| Chen, M; Huang, W; Kang, Z; Li, Q; Liu, T; Shu, Y; Zhang, W; Zhou, H | 1 |
| Liu, LP; Wang, L; Wang, ZH | 1 |
| Bae, GS; Chu, H; Kim, CH; Kim, Y; Lee, S; Leem, J; Wi, M | 1 |
| Bashiri, R; Ghadiri-Anari, A; Gheflati, A; Kord, MT; Nadjarzadeh, A; Reza, JZ | 1 |
| Andreeva-Gateva, PA; Dimova, II; Mihaleva, ID | 1 |
| Bucciantini, M; Caselli, A; Garagna, S; Giorgetti, S; Leri, M; Luti, S; Marchese, L; Natalello, A; Paoli, P; Rebuzzini, P; Stefani, M | 1 |
| Agustina, PS; Angianto, AR; Damanik, J; Kristanti, M; Mayza, A; Prawiroharjo, P; Rachman, A; Sauriasari, R; Yunir, E | 1 |
| Ahn, CW; Fang, S; Kim, J; Lee, HS; Park, JS | 1 |
| Hirota, Y; Ogawa, W; Okada, Y; Sakaguchi, K; Sugawara, K | 1 |
| Cheng, H; Zhao, W; Zhu, Y | 1 |
| Cheng, X; Liu, W; Ma, N; Wu, M; Xu, N; Yin, D | 1 |
| Cao, P; Chan, L; Chan, P; Chang, Z; Chao, Y; Chen, Z; Deng, B; Lyu, Q; Pan, Y; Que, R; Tan, EK; Wang, Q; Wang, T; Wang, Y; Xu, L; Yang, W; Yenari, MA; Yuan, F; Zhu, S | 1 |
| Liu, Z; Ma, C; Zhao, Y | 1 |
| Hou, L; Huo, C; Jia, X; Lei, Y; Li, X; Liu, Y; Sun, C; Wang, X; Xu, R; Yang, J | 1 |
| El-Sherif, M; Esmael, A; Hashem, MM; Nassar, AK | 1 |
| Barani, VY; Bedey, NV; Petrichko, OI; Sirchak, YS | 1 |
| Azimzadeh, M; Darvishhoo, N; Jelodar, G; Radmard, F | 1 |
| Fu, C; Gao, Y; Wang, Q; Xia, H | 1 |
| Diao, J; Ding, S; Du, A; Wen, S; Yuan, X; Zhou, L | 1 |
| Dong, N; Shi, H; Tang, X | 1 |
| Cao, Y; Jiang, Y; Kong, X; Li, P; Liu, Q; Ma, L; Yan, M; Zhang, H; Zhao, H; Zhao, T | 1 |
| Cai, R; Han, J; Huang, R; Shen, Y; Sun, J; Tian, S; Wang, S | 1 |
| Adedeji, TA; Akintunde, AA; Ala, OA; Ala, OO; Ikem, RT; Kolawole, BA | 1 |
| Emoto, M; Fujii, H; Fukumoto, S; Inaba, M; Kabata, D; Kuwamura, Y; Mori, K; Morioka, T; Motoyama, K; Naganuma, T; Okute, Y; Shima, H; Shimono, T; Shintani, A; Shioi, A; Shoji, T; Sonoda, M | 1 |
| Chen, Y; Guo, X; Li, Z; Sun, Y; Wang, H; Xu, J | 1 |
| Ferdous, SA; Hoque, M; Majumder, M; Mollah, FH | 1 |
| Breitenstein, MK; Cairns, J; Caraballo, PJ; Moore, JH; Olson, RS; Orlenko, A; Orzechowski, P; Wang, L; Weinshilboum, RM | 1 |
| Borowska, M; Dworacka, M; Krzyżagórska, E; Winiarska, H | 1 |
| Chen, W; Guo, H; Han, X; He, M; Hu, H; Liang, Y; Miao, X; Tang, Y; Wang, F; Wang, J; Wang, Y; Wei, S; Wu, T; Yang, H; Yao, P; Yu, C; Yuan, J; Zhang, X; Zheng, D | 1 |
| Karachentsev, I; Kravchun, N; Polozova, L; Sinaiko, V; Zemlianitsyna, O | 1 |
| Cao, Y; Jiang, Y; Kong, X; Li, P; Liu, P; Liu, Q; Ma, L; Yan, M; Zhang, H; Zhao, H; Zhao, T | 1 |
| Fu, S; Guo, Y; Luo, L; Ye, P; Zhang, Z | 1 |
| Eriksen, JN; Kristensen, M; Lauritzen, L; Lind, MV; Ross, AB | 1 |
| Cao, Y; Jiang, Y; Li, P; Liu, Q; Ma, L; Niu, W; Zhao, H; Zhao, T | 1 |
| Feng, J; Jiang, C; Kong, W; Li, Y; Pang, Y; Wang, X; Xiang, X; Xu, G; Xu, M; Zhang, H | 1 |
| Arinsoy, T; Bahar, B; Derici, UB; Koluman, BU; Mutluay, R; Oktan, SO; Sancak, B; Senlik, Z; Sindel, S | 1 |
| Drzewoski, J; Kamysz, W; Karafova, A; Karolczak, K; Watala, C | 1 |
| Chen, L; Chen, YM; Ling, WH; Tan, YZ; Wang, LJ; Wei, J; Yang, Y; Zhou, JY; Zhu, HL | 1 |
| Atamer, A; Atamer, Y; Can, AS; Hekimoğlu, A; Ilhan, N; Koçyiğit, Y; Yenice, N | 1 |
| Bernardini, S; Bocedi, A; Dessì, M; Di Daniele, N; Fabrini, R; Noce, A; Pastore, A; Ricci, G; Rovella, V; Santini, S; Tesauro, M | 1 |
| Li, D | 1 |
| Aizawa, T; Funase, Y; Ouchi, K; Sato, Y; Yamauchi, K | 1 |
| Huang, J; Huang, T; Li, D; Ren, J | 1 |
| Finer, S; Hitman, G; Saravanan, P; Yajnik, C | 1 |
| Jianbo, L; Jiawei, C; Mei, Y; Xie, M; Yan, L; Zhang, H | 1 |
| Li, J; Shi, M; Xie, M; Yan, L; Zhang, H | 1 |
| Akalin, A; Arabul, M; Celik, M; Cerrah, S | 1 |
| Apergis, G; Dimitriadis, G; Fotiou, P; Raptis, A; Theodossiadis, P; Vergados, I | 1 |
| Ahmed, M; Errett, L; Jenkins, DJ; Keith, M; Kuliszewski, MA; Leong-Poi, H; Liao, C; Peeva, V; Sorokin, K; Tran, S | 1 |
| Chambers, ST; Elmslie, JL; George, PM; Krebs, JD; Lever, M; Lunt, H; McEntyre, CJ; Parry-Strong, A; Slow, S | 1 |
| Chen, Y; Huang, T; Li, D; Sun, J; Xie, H; Xu, D | 1 |
| Callà, C; De Stefano, A; Dessì, M; Di Daniele, N; Di Giovamberardino, G; Noce, A; Pastore, A; Zenobi, R | 1 |
| Hu, C; Wan, B; Wang, H; Xiao, SH | 1 |
| Alis, R; Hernández-Mijares, A; Pareja-Galeano, H; Rocha, M; Romagnoli, M; Sanchis-Gomar, F; Víctor, VM | 1 |
| Liu, G; Liu, X; Wang, F; Wu, Y; Xu, C; Yu, J | 1 |
| Dimitriadis, G; Kontoangelos, K; Lambadiari, V; Papadimitriou, GN; Papageorgiou, CC; Rabavilas, AD; Raptis, AE; Raptis, SA; Tsiotra, P | 1 |
| Anjum, F; Bukhari, SA; Farooq, M; Javed, S; Nagra, SA; Naqvi, SA | 1 |
| Ali, M; Bukhari, SA; Javed, S; Rehman, M; Shahzadi, A | 1 |
| Gilowski, W; Krysiak, R; Okopien, B; Szkrobka, W | 1 |
| Assareh, H; Jelinek, H; Ke, H; Leng, YLY; McCabe, J; McLachlan, CS; Zhou, Y | 1 |
| Alibrandi, A; Cucinotta, D; Forte, F; Gambadoro, N; Giandalia, A; Perdichizzi, G; Romeo, EL; Russo, GT; Scarcella, C; Zingale, R | 1 |
| Huo, Y; Qin, X | 1 |
| Abd-Allah, GM; Hassan, MH | 1 |
| Charles, S; Ifebi, E; Kyte, B; Liu, F; Shrestha, S; Zhang, J | 1 |
| Kuchma, N; Murenets, N; Orlovskiy, A; Orlovskiy, V | 1 |
| Di, F; Gao, L; Jia, G; Li, N; Li, Q; Shao, J; Wang, L; Wang, Q | 1 |
| Chen, S; Chen, Z; Duan, S; Fan, R; Han, L; Hao, Y; Liu, S; Ma, J; Peng, X; Wang, C; Wu, Q; Zhang, L; Zhang, T | 1 |
| Yamauchi, M | 1 |
| Beilin, LJ; Burke, V; Hodgson, JM; Mori, TA; Puddey, IB; Zilkens, RR | 1 |
| Ding, X; Gong, Q; He, Y; Li, S; Liu, C; Liu, Z; Mao, X; Na, R; Qu, Y; Wang, H; Xing, X; Xu, R | 1 |
| Aroda, VR; Bray, GA; Crandall, JP; Edelstein, SL; Goldberg, RB; Knowler, WC; Marcovina, SM; Orchard, TJ; Schade, DS; Temprosa, MG; White, NH | 1 |
| Ates, I; Barca, AN; Cetin, M; Kiziltunc, E; Kundi, H; Ornek, E; Ozkayar, N | 1 |
| Ahamed, R; Baipadithaya, G; Balakrishnan, A; Hegde, M; Joshi, MB; Nagri, SK; Ramachandra, L; Satyamoorthy, K; Vohra, M | 1 |
| Chen, WB; Lin, YZ; Lv, D; Xie, F | 1 |
| Borettaz, I; D'angelo, A; Derosa, G; Esposito, P; Libetta, C; Maffioli, P; Tinelli, C | 1 |
| Alessi, E; Asztalos, B; Cucinotta, D; Di Benedetto, A; Gaudio, A; Giandalia, A; Horvath, KV; Ientile, R; Raimondo, G; Russo, GT | 1 |
| Contant, CF; Francone, OL; Gao, X; Lewin, AJ; Nguyen, TT; Terra, SG | 1 |
| Ajmi, T; Chaeib, L; Hammami, M; Issaoui, M; Kassab, A; Miled, A | 1 |
| Changyu, P; Guoqing, Y; Jingtao, D; Juming, L; Qinghua, G; Weijun, G; Yiming, M | 1 |
| Corretti, V; Ferrannini, E; Madec, S; Santini, E; Solini, A | 1 |
| Dou, J; Gu, W; Lu, J; Meng, J; Mu, Y; Pan, C; Yang, G | 1 |
| Bilge, F; Cakal, E; Gisi, K; Kilinc, M; Ozkaya, M; Sahin, M | 1 |
| Jelinek, H; Kerr, RG; Nwose, EU; Richards, RS; Tinley, R | 1 |
| Alexandru, N; García-Estañ, J; Jardín, I; Popov, D; Rosado, JA; Salido, GM; Simionescu, M | 2 |
| Alibegovic, AA; Dela, F; Højbjerre, L; Sonne, MP; Stallknecht, B; Vaag, A | 1 |
| Ran, XW; Yu, TT | 1 |
| Cheng, X; Luo, D; Song, Y; Yan, S | 1 |
| Barter, PJ; Ehnholm, C; Keech, AC; Simes, RJ; Sullivan, DR; Taskinen, MR; Whiting, M; Zannino, D | 1 |
| Albert, CM; Cook, NR; Manson, JE; Song, Y; Van Denburgh, M | 1 |
| Eshraghian, MR; Jalali, MD; Jazayery, AD; Pooya, Sh; Saedisomeolia, A; Toorang, F | 1 |
| Eminagaoglu, S; Erem, C; Ersoz, HO; Hacihasanoglu, AB; Karahan, C; Kocak, M; Ukinc, K; Yilmaz, M | 1 |
| Bhat, DS; Fall, CH; Joglekar, CV; Johnston, C; Lubree, HG; Naik, SS; Ramdas, LV; Refsum, H; Thuse, NV; Yajnik, CS | 1 |
| Demidova, VS; Doguzhieva, RM; Egorova, VV; Emel'ianov, DR; Lebedeva, AN; Pokrovskiĭ, AV; Titova, MI | 1 |
| Bayindir, O; Görmüş, U; Mutaf, I; Ozdoğan, O; Ozmen, B; Ozmen, D; Parildar, Z | 1 |
| Cardoso, JE; Carvalho, MG; Dusse, LM; Fernandes, AP; Lages, GF; Lasmar, MC; Lwaleed, BA; Novelli, BA; Soares, AL; Sousa, MO; Vieira, LM | 1 |
| Burdan, F; Dworzański, W; Opielak, G | 1 |
| Brazionis, L; Itsiopoulos, C; Jenkins, A; O'Dea, K; Rowley, K; Wong, TY; Yau, J | 1 |
| Abellán, MR; Ascaso, JF; Carmena, R; Catalá, M; Chaves, FJ; González, R; Lorente, R; Martínez-Hervás, S; Pedro, T; Priego, A; Real, JT | 1 |
| Chang, PY; Chen, CH; Lee, YT; Lu, SC | 1 |
| Doupis, J; Eleftheriadou, I; Gonis, A; Katsilambros, N; Kokkinos, A; Pavlatos, S; Perrea, D; Tentolouris, N | 1 |
| Bartegi, A; López, JJ; Redondo, PC; Rosado, JA; Salido, GM; Zbidi, H | 1 |
| Bets, D; de Jager, J; Donker, AJ; Kooy, A; Lehert, P; Stehouwer, CD; van der Kolk, J; Verburg, J; Wulffelé, MG | 1 |
| Kuswardhani, RA; Suastika, K | 1 |
| Almawi, WY; Jawad, LH; Juma, EA; Keleshian, SH; Nemr, R; Salman, RA | 1 |
| Aouni, Z; El Oudi, M; Machghoul, S; Mazigh, C; Ouertani, H | 1 |
| Bhopal, RS; Rafnsson, SB; Saravanan, P; Yajnik, CS | 1 |
| Barbagallo, M; Belvedere, M; Ciaccio, M; Costanza, G; Dominguez, LJ; Ferlisi, A; Galioto, A; Pineo, A; Putignano, E | 1 |
| Best, JD; Brazionis, L; Cameron, M; Itsiopoulos, C; Kaimakamis, M; O'Dea, K; Rowley, K | 1 |
| Sabanayagam, C; Shankar, A | 1 |
| Froghifar, N; Gohari, M; Hosseini, S; Rajab, A; Shidfar, F; Shidfar, S; Vafa, M | 1 |
| Anan, F; Eshima, N; Fujiki, M; Kobayashi, H; Masaki, T; Saikawa, T; Shimomura, T; Umeno, Y; Yoshimatsu, H | 1 |
| Bailbe, D; Coulaud, J; Ehses, J; Homo-Delarche, F; Janel, N; Lacraz, G; Noll, C; Paul, JL; Portha, B | 1 |
| Hongxing, W; Jianbo, L; Jiawei, C; Jingrong, T; Ming, S; Qing, D; Yu, Z; Yuche, C | 1 |
| Badeau, R; Hiukka, A; Jauhiainen, M; Maranghi, M; Sundvall, J; Taskinen, MR | 1 |
| Alibegovic, AC; Dela, F; Højbjerre, L; Nielsen, LB; Sonne, MP; Stallknecht, B; Vaag, AA | 1 |
| Abdel Rahman, TT; Ali, DR; Amer, MS; Omar, OH; Reda, RA | 1 |
| Abete, I; Martínez, JA; Navas-Carretero, S; Zulet, MA | 1 |
| Schalinske, KL; Williams, KT | 1 |
| Aghamohammadi, V; Aliasgharzadeh, A; Gargari, BP | 1 |
| Guo, HQ; Hao, HR; Hong, B; Ma, SG; Wang, ZJ; Wei, CL; Wu, XJ; Xu, W | 1 |
| Bharadwaj, D; Chauhan, G; Dwivedi, OP; Ghosh, S; Kaur, I; Tabassum, R; Tandon, N | 1 |
| Baffero, E; Collaviti, S; Coppola, A; Gallotti, P; Garzaniti, A; Gazzaruso, C; Giustina, A; Grugnetti, A; Montalcini, T; Pelissero, G; Pujia, A; Solerte, SB | 1 |
| Kimura, S; Matsushita, M; Ohta, T; Sasase, T; Sato, E | 1 |
| Chen, HH; Jin, QH; Li, TL; Li, XC; Liu, Z; Wang, S; Xu, L | 1 |
| Brazionis, L; Itsiopoulos, C; O'Dea, K; Walker, KZ | 1 |
| Badr, GA; El Boghdady, NA | 1 |
| Chen, J; Li, J; Shi, M; Xie, M; Yan, L; Zhang, H; Zhu, Y; Zhuang, L | 1 |
| Chambers, ST; Dellow, WJ; George, PM; Lever, M; McGregor, DO; Slow, S | 1 |
| Cao, HF; Chi, BJ; Gui, SL; Guo, YG; Ma, HB; Qin, WB; Teng, F; Wang, SQ | 1 |
| Demidova, VS; Doguzhieva, RM; Lebedeva, AN; Pokrovskiĭ, AV | 1 |
| Asimi, S; Huang, T; Li, D; Lou, D | 1 |
| Incampa, S; Jaiyen, S; Khaithong, W; Saokaew, S; Sridetch, S; Sudchada, P | 1 |
| Ascaso, JF; Carmena, R; Catalá, M; Chaves, FJ; Civera, M; González, R; Martinez-Hervas, S; Pedro, T; Priego, MA; Real, JT | 1 |
| Inokuchi, N; Kishikawa, H; Mori, H; Okada, Y; Sugimoto, H; Tanaka, Y | 1 |
| Içağasioğlu, S; Kiliçli, F; Korkmaz, S; Yildiz, G; Yilmaz, A | 1 |
| Ebesunun, MO; Obajobi, EO | 1 |
| Cunha, SF; Foss-Freitas, MC; Mello, AL; Vannucchi, H | 1 |
| Bicho, M; Bronze, MR; Costa, HS; Duarte, R; Valente, A | 1 |
| Ascaso, JF; Chaves, FJ; Folgado, J; Gonzalez, R; Lorente, R; Martínez-Hervás, S; Molina, M; Priego, A; Real, JT | 1 |
| Guo, Q; Lu, J; Pan, C | 1 |
| Abdella, N; Akanji, AO; Al Mohammedi, H; Mojiminiyi, OA; Moussa, MA; Zaki, M | 1 |
| Bayindir, O; Habif, S; Mutaf, I; Ozmen, B; Ozmen, D; Turgan, N | 1 |
| Bravi, MC; Cassone Faldetta, M; De Luca, O; De Mattia, G; Desideri, G; Ferri, C; Laurenti, O; Marinucci, MC | 1 |
| Ghitescu, L; Gugliucci, A | 1 |
| Bostom, AG; Friedman, AN; Hunsicker, LG; Selhub, J | 2 |
| Agulló-Ortuño, MT; Albaladejo, MD; Fenollar, M; Martínez, P; Parra, S; Rodríguez-Manotas, M; Ruíz-Espejo, F; Tebar, J | 1 |
| Abdella, NA; Akanji, AO; Mojiminiyi, OA; Moussa, MA | 1 |
| Benmerabet, S; Candito, M; Canivet, B; Fredenrich, A; Robillon, JF; Van Obberghen, E | 1 |
| Deng, H; Fan, Y; Lu, H; Sun, J; Sun, S; Xu, Y; Zhang, Y; Zhu, Y | 2 |
| Blom, HJ; Den Heijer, M; Hermus, AR; Pouwels, MJ; Tack, CJ | 1 |
| Burke, V; Croft, KD; Playford, DA; Watts, GF | 1 |
| Aller, R; Arranz, M; de Luis, DA; De Luis, J; Fernandez, N; Izaola, O | 1 |
| Ciccarelli, L; Crescenzi, G; Derosa, G; Fogari, R; Mugellini, A | 1 |
| Fagot-Campagna, A; Gunter, EW; Hanson, RL; Knowler, WC; Looker, HC; Narayan, KM; Pfeiffer, CM | 1 |
| Braun, A; Busch, M; Fleck, C; Franke, S; Müller, A; Müller, UA; Schiel, R; Stein, G | 1 |
| Becker, A; Bouter, LM; Dekker, JM; Heine, RJ; Henry, RM; Jakobs, C; Kostense, PJ; Nijpels, G; Smulders, YM; Stehouwer, CD; Teerlink, T; Zweegman, S | 1 |
| Calzoni, F; Fellin, R; Nora, ED; Pareschi, PL; Passaro, A; Solini, A; Volpato, S; Zamboni, PF | 1 |
| Aso, Y; Inukai, T; Okumura, K; Takebayashi, K; Wakabayashi, S | 1 |
| Aso, Y; Okumura, K | 1 |
| Duman, BS; Hatemi, H; Oztürk, M; Yilmazeri, S | 1 |
| Archetti, S; Assanelli, D; Capani, F; Ciccarone, E; Di Castelnuovo, A; Donati, MB; Iacoviello, L; Ruggeri, G; Salcuni, N | 1 |
| García-Idoate, G; Mora, C; Muros, M; Navarro, JF | 1 |
| Clement, L | 1 |
| Emiliani, S; Panini, R; Salvioli, G; Ventura, P | 1 |
| Alessi, E; Crisafulli, G; Cucinotta, D; Di Benedetto, A; Di Cesare, E; Giorda, C; Ientile, R; Jacques, PF; Raimondo, G; Russo, GT | 1 |
| Frohlich, J; Genest, J; Steiner, G | 1 |
| Cieślik, G; Idzior-Waluś, B; Sieradzki, J; Waluś, M | 1 |
| Ceresini, G; Destro, T; Ferrari, E; Fioravanti, M; Gazzaruso, C; Locatelli, E; Schifino, N; Solerte, SB | 1 |
| Al-Waili, NS | 1 |
| Lu, H; Sun, J; Xu, Y; Zhu, Y | 2 |
| Brain, AM; Child, DF; Davies, GK; De, P; Harvey, JN; Hudson, PR; Jones, H; Mukherjee, S; Williams, CP | 1 |
| Ciccarelli, L; Derosa, G; Fogari, R; Franzetti, I; Gadaleta, G | 1 |
| Aso, Y; Inukai, T; Matsutomo, R; Okumura, K; Takebayashi, K; Wakabayashi, S; Yoshida, N | 1 |
| Dobordzhginidze, LM | 1 |
| Chattananon, A; Pongchaidecha, M; Srikusalanukul, V; Tanjariyaporn, S | 1 |
| Bessomo, A; Buysschaert, M; Gala, JL; Hermans, MP | 1 |
| Botezat, M; Cojocaru, IM; Druţă, A; Muşuroi, C; Oprişan, A; Uscatescu, V | 1 |
| Aggarwal, SP; Narang, AP; Sandhu, JS; Sandhu, P; Singh, I | 1 |
| Lu, H; Sun, J; Xu, Y; Xue, J; Zhu, Y | 1 |
| Becker, A; Bouter, LM; Dekker, JM; Heine, RJ; Henry, RM; Jakobs, C; Kostense, PJ; Nijpels, G; Smulders, YM; Spijkerman, AM; Stehouwer, CD; Teerlink, T | 1 |
| Halvorsen, B; Ranheim, T | 1 |
| Gallagher, A; Home, PD | 1 |
| Elias, AN; Eng, S | 1 |
| Charvát, J; Chlumský, J; Kvapil, M; Michalová, K; Táborská, K; Vojácek, J | 1 |
| Asonganyi, B; Jackson, SH; Mangoni, AA; Sherwood, RA; Swift, CG; Thomas, S | 1 |
| Ansquer, JC; Foucher, C; Rattier, S; Steiner, G; Taskinen, MR | 1 |
| Li, W; Li, WP; Yang, T | 1 |
| Fowler, B; Herrmann, W; Kuhlmann, MK; Makowski, J; Obeid, R; Schorr, H | 1 |
| Hickie, I; Mitchell, P; Naismith, S; Parker, G; Scott, E; Ward, PB; Wilhelm, K | 1 |
| D'Almeida, V; Dabela, ML; Fonseca, FA; Helfenstein, T; Izar, MC; Matheus, SC; Relvas, WG; Rodrigues, PR; Santos, AO; Sousa, EF; Souza, FG; Taglieri, R; Tufik, S | 1 |
| Cetinalp, P; Kuskay, S; Maral, H; Ozdemir, G; Ozden, M; Tarkun, I | 1 |
| Alikasifoglu, M; Erbas, T; Tuncbilek, E; Tutuncu, NB | 1 |
| Ito, T; Sakuta, H; Suzuki, T; Yasuda, H | 2 |
| Diakoumopoulou, E; Doulgerakis, D; Katsilambros, N; Kirlaki, E; Kitsou, E; Perrea, D; Psallas, M; Tentolouris, N | 1 |
| Bossone, E; Distante, A; Mazza, A; Mazza, F | 1 |
| Araki, A; Hosoi, T; Ito, H; Orimo, H | 1 |
| Domínguez, RO; Famulari, AL; Guareschi, EM; Marschoff, ER; Pagano, MA; Serra, JA | 1 |
| Hellgren, M; Lindblad, U; Melander, A; Ostgren, CJ; Råstam, L | 1 |
| Kinalska, I; Kowalska, I; Rudy, A; Straczkowski, M | 1 |
| Bets, D; Donker, AJ; Kooy, A; Lehert, P; Stehouwer, CD; Wulffelé, MG | 1 |
| Konukoğlu, D; Serin, O; Turhan, MS | 1 |
| Czarnecka, D; Idzior-Waluś, B; Kawecka-Jaszcz, K; Małek, A; Miarka, P; Sieradzki, J; Sztefko, K; Waluś-Miarka, M | 1 |
| Hitoglou-Makedou, AD; Kazakos, KA; Lasaridis, AN; Mouslech, TF; Nilsson, PM; Sarafidis, PA; Stafylas, PC; Tourkantonis, AA; Yovos, JG | 1 |
| Ceska, R; Dolezalova, R; Kasalova, Z; Krejci, H; Stulc, T | 1 |
| Ito, T; Katayama, Y; Sakuta, H; Suzuki, T; Yasuda, H | 1 |
| Coracina, A; Garibotto, G; Kiwanuka, E; Tessari, P; Valerio, A; Vedovato, M; Vettore, M; Zaramella, M | 1 |
| Brennan, SL; Budge, MM; Elias, MF; Elias, PK; Robbins, MA | 1 |
| Müftüoglu, F; Yücel, G; Yücel, I | 1 |
| Brosnan, JT; Brosnan, ME; Hall, B; Ratnam, S; Wijekoon, EP; Zeisel, SH | 1 |
| Bouter, LM; Dekker, JM; Heine, RJ; Nijpels, G; Smulders, YM; Spoelstra-De Man, AM; Stehouwer, CD | 1 |
| Písaríková, A; Stanková, B; Tvrzická, E; Vecka, M; Zák, A; Zeman, M | 1 |
| Chang, MH; Chen, TH; Chen, YJ; Hsu, HH; Huang, CY; Huang, EJ; Kuo, WW; Lee, SD; Lu, MC; Tzang, BS | 1 |
| Borni, Z; Brahim, N; Chahib, M; Habib, H; Hédi, M; Olfa, E; Oudi, M; Salem, M; Zied, A | 1 |
| Hofer, M; Krugluger, W; Krzyzanowska, K; Mittermayer, F; Schernthaner, G; Schnack, C; Wolzt, M | 1 |
| Gannon, MC; Nuttall, FQ | 1 |
| Li, CJ; Li, H; Si, XW; You, QY; Zhu, QQ | 1 |
| Fukushima, M; Kuroe, A; Nakai, Y; Ohgushi, M; Ohya, M; Seino, Y; Taniguchi, A | 1 |
| Falcone, JC; Fleming, JT; Joshua, IG; Passmore, JC; Rodriguez, WE; Tyagi, N; Tyagi, SC | 1 |
| Föger, B | 1 |
| Amayo, EO; Ogola, EN; Otieno, CF; Vaghela, V | 1 |
| Lu, JM; Ma, FL; Pan, CY; Yang, GQ; Zheng, H; Zou, XM | 1 |
| Alessi, E; Antico, A; Cucinotta, D; Di Benedetto, A; Di Cesare, E; Ientile, R; La Scala, R; Nicocia, G; Raimondo, G; Russo, GT | 1 |
| Braun, S; Kastrati, A; Koch, W; Kölling, K; Mehilli, J; Ndrepepa, G; Schömig, A | 2 |
| Almawi, WY; Aouni, Z; Chaieb, A; Chaieb, M; Ezzidi, I; Mahjoub, T; Marmouche, H; Mtiraoui, N; Vaxillaire, M | 1 |
| Bennett, PH; Fagot-Campagna, A; Gunter, EW; Hanson, RL; Knowler, WC; Looker, HC; Nelson, RG; Pfeiffer, CM; Sievers, ML | 1 |
| Jordao, AA; Meirelles, MS; Melo, SS; Persuhn, DC; Vannucchi, H | 1 |
| Balletshofer, BM; Fritsche, A; Häring, HU; Müssig, K; Schäfer, SA; Stefan, N | 1 |
| Ciccarelli, L; Cicero, AF; D'Angelo, A; Derosa, G; Ferrari, I; Gravina, A; Montagna, L; Paniga, S; Piccinni, MN; Pricolo, F; Ragonesi, PD; Salvadeo, SA | 1 |
| Giddens, K; McQueen, MJ; Nassar, BA; Title, LM; Ur, E | 1 |
| Anan, F; Eshima, N; Masaki, T; Nakagawa, M; Saikawa, T; Takahashi, N; Yonemochi, H; Yoshimatsu, H | 1 |
| Bouzid, C; Essais, O; Ibrahim, H; Machghoul, S; Ouertani, H; Ouni, Z; Zidi, B | 1 |
| Böger, CA; Christ, J; Götz, AK; Haak, T; Hoffmann, U; Krämer, BK; Riegger, GA; Stubanus, M | 1 |
| Balogh, E; Bereczky, Z; Boda, K; Császár, A; Czuriga, I; Edes, I; Ferdinandy, P; Kónya, C; Koszegi, Z; Muszbek, L | 1 |
| Al-Ozairi, E; Horton, ES; Middelbeek, RJ | 1 |
| Vergès, B | 1 |
| Alaveras, A; Harris, F; Kalofoutis, A; Kalofoutis, C; Phoenix, D; Piperi, C; Singh, J; Zisaki, A | 1 |
| Almeida, OP; Flicker, L; Hankey, GJ; Jamrozik, K; Norman, P; van Bockxmeer, FM; Vasikaran, S | 1 |
| Armani, U; Cerone, R; Leoncini, G; Minniti, G; Piana, A; Signorello, MG; Viviani, GL | 1 |
| Cui, RZ; Li, Y; Li, YL; Qin, Q; Wang, H; Zhao, BR; Zhao, FM | 1 |
| Guéant, JL; Peyrin-Biroulet, L; Roblin, X | 1 |
| Anai, M; Anan, F; Chiba, S; Gotoh, K; Higuchi, K; Kakuma, T; Katsuragi, I; Masaki, T; Tanaka, K; Tsubone, T; Yoshimatsu, H | 1 |
| Phelip, JM; Roblin, X | 1 |
| Stühlinger, M | 1 |
| Grover-Páez, F; Guillén Ortíz, R; Villegas Rivera, G | 1 |
| Fukushima, M; Inagaki, N; Kitatani, N; Kuroe, A; Nagasaka, S; Nakai, Y; Ohgushi, M; Ohya, M; Seino, Y; Taniguchi, A | 1 |
| Dou, JT; Gu, WJ; Guo, QH; Lu, JM; Mu, YM; Pan, CY; Yang, GQ | 1 |
| Pofelski, J; Roblin, X; Zarski, JP | 1 |
| Cam, S; Karabag, T; Kaya, A; Koç, F; Temizhan, A; Yavuz, S | 1 |
| Carvalho, Md; Dusse, LM; Fernandes, AP; Lages, Gde F; Lasmar, MC; Novelli, BA; Soares, AL; Sousa, Mde O | 1 |
| Ehnholm, C; Hiukka, A; Jauhiainen, M; Keech, AC; Leinonen, E; Sundvall, J; Taskinen, MR | 1 |
| Alina, AR; Bondar', IA; Pechkovskiĭ, EV; Pikalov, IV | 1 |
| Ito, T; Sakuta, H; Suzuki, T | 1 |
| Anan, F; Eshima, N; Masaki, T; Saikawa, T; Umeno, Y; Yonemochi, H; Yoshimatsu, H | 1 |
| Bouter, LM; Dekker, JM; Heine, RJ; Jakobs, C; Nijpels, G; Polak, BC; Stehouwer, CD; Stolk, RP; Teerlink, T; Van Hecke, MV | 1 |
| Bang, H; Hussain, SI; Newman, GC; Toole, JF | 1 |
| Akalin, A; Alatas, O; Colak, O | 1 |
| Anan, F; Eshima, N; Fujiki, M; Kobayashi, H; Saikawa, T; Shimomura, T; Umeno, Y; Yoshimatsu, H | 1 |
| Aydemir, O; Celiker, U; Güler, M; Metin, K; Türkçüoğlu, P; Ustündağ, B; Yilmaz, T | 1 |
| Araki, A; Ito, H; Sako, Y | 1 |
| Fink, L; Fonseca, V; Munshi, MN; Stone, A | 1 |
| Aljada, A; Baliga, BS; Dandona, P; Fink, L; Fonseca, VA; Munshi, M; Stone, A; Thusu, K | 1 |
| Bouter, LM; Heine, RJ; Hoogeveen, EK; Jakobs, C; Kostense, PJ; Stehouwer, CD | 1 |
| Beks, PJ; Bouter, LM; Heine, RJ; Hoogeveen, EK; Jakobs, C; Kostense, PJ; Mackaay, AJ; Stehouwer, CD | 1 |
| Fink, LM; Fonseca, VA; Henry, RR; Kern, PA; Mudaliar, S; Schmidt, B | 1 |
| Bouter, LM; Donker, AJ; Heine, RJ; Hoogeveen, EK; Jager, A; Jakobs, C; Kostense, PJ; Stehouwer, CD | 1 |
| Arcelús, R; Blanco-Vaca, F; Carreras, G; Chico, A; Córdoba, A; de Leiva, A; González-Sastre, F; Pérez, A | 1 |
| Astorri, E; Craveri, A; Dall'Aglio, P; Fiorina, P; Lanfredini, M; Mello, A; Peca, MG; Veronelli, A | 1 |
| Astorri, E; Craveri, A; Fiorina, P; Lanfredini, M; Mello, A; Montanari, A; Peca, MG; Veronelli, A | 1 |
| Gall, MA; Hougaard, P; Jakobs, C; Parving, HH; Stehouwer, CD | 1 |
| Berglund, L; Berne, C; Brattström, L; Refsum, H; Ueland, PM; Wollesen, F | 1 |
| Aarsand, AK; Carlsen, SM | 1 |
| Brouwer, CB; Silberbusch, J; Smulders, YM | 1 |
| Asazuma, K; Eguchi, K; Kosaka, S; Miyamori, I; Oida, K; Okada, E; Tada, H; Takahashi, S; Tohda, G | 1 |
| Odekerken, DA; Rakic, M; Sijbrands, EJ; Silberbusch, J; Slaats, EH; Smulders, YM; Stehouwer, CD; Treskes, M | 1 |
| Allen, RH; Cohen, JA; Estacio, R; Jeffers, BW; Schrier, RW; Stabler, SP | 1 |
| Chait, A; Clark, S; Hatton, DC; Haynes, RB; Holcomb, S; Kris-Etherton, P; McCarron, DA; McMahon, M; Metz, JA; Morris, CD; Oparil, S; Pi-Sunyer, FX; Resnick, LM; Snyder, GW; Stern, JS | 1 |
| Ammaturo, V; Andreotti, F; Bianco, P; Cortese, C; Federici, G; Mazza, A; Motti, C; Nulli, A; Pastore, A; Santoro, E | 1 |
| Chan, JC; Chan, N | 1 |
| Chait, A; Clark, S; Eastgard, RL; Hatton, DC; Haynes, RB; Holcomb, S; Kris-Etherton, P; Malinow, MR; McCarron, DA; McMahon, M; Metz, JA; Morris, CD; Nevin, DN; Oparil, S; Pi-Sunyer, FX; Resnick, LM; Reusser, ME; Snyder, GW; Stern, JS | 1 |
| Bald, E; Chwatko, G; Czupryniak, L; Drzewoski, J | 2 |
| Andreotti, F; Cortese, C; Giugliano, D; Marra, G; Mazza, A; Motti, C; Nulli, A | 1 |
| Calzoni, F; Carantoni, M; D'Elia, K; Fellin, R; Pareschi, PL; Passaro, A; Solini, A | 1 |
| Chan, NN | 1 |
| Hanefeld, M; Julius, U; Menschikowski, M; Pietzsch, J; Pixa, A | 1 |
| Bouter, LM; Dekker, JM; Gerritsen, J; Heine, RJ; Jager, A; Nijpels, G; Smulders, YM; Stehouwer, CD | 1 |
| Becker, A; Bouter, LM; Dekker, JM; Heine, RJ; Jager, A; Kostense, PJ; Nijpels, G; Stehouwer, CD; Van Hinsbergh, VW | 1 |
| Ben-Yehuda, A; Friedlander, Y; Friedman, G; Goldschmidt, N; Raz, I; Shpichinetsky, V; Wexler, ID | 1 |
| Abdella, N; Akanji, AO; Mojiminiyi, OA | 1 |
| Buysschaert, M; Dramais, AS; Hermans, MP; Wallemacq, PE | 1 |
| Garber, AJ | 1 |
| Bouter, LM; Dekker, JM; Donker, AJ; Heine, RJ; Jager, A; Kostense, PJ; Nijpels, G; Stehouwer, CD | 1 |
| Brock, B; Carstensen, M; Hermansen, K; Høie, L; Søndergaard, M | 1 |
| Emoto, M; Inaba, M; Ishimura, E; Kanda, H; Kawagishi, T; Komatsu, M; Mori, K; Nishizawa, Y; Okuno, Y; Shoji, T; Tahara, H | 1 |
| Ambrosch, A; Dierkes, J; König, W; Kühne, W; Lehnert, H; Lobmann, R; Luley, C | 1 |
| Cohen, JA; Estascio, R; Jeffers, BW; Schrier, RW; Stabler, S | 1 |
| Fumelli, P; Martarelli, D; Mazzanti, L; Moretti, N; Mutus, B; Rabini, RA; Ricciotti, R; Staffolani, R | 1 |
| Clifton-Bligh, P; Davies, L; Fulcher, GR; Gunton, J; McElduff, A; Wilmshurst, EG | 1 |
| Sun, J; Xu, Y; Zhu, Y | 1 |
| Florczak, K; Penckofer, S; Schwertz, D | 1 |
| Aller, R; Arranz, M; de Luis, DA; Fernandez, N; Izaola, O | 1 |
| Cassader, M; Cavallo-Perin, P; Gai, M; Gambino, R; Lillaz, E; Pagano, G; Rolfo, E; Scaglione, L | 1 |
| Breteler, MM; Clarke, R; Donald, A; Holman, R; Jacques, P; Johnston, C; Lewington, S; Refsum, H; Stratton, I | 1 |
| Caixàs, A; Deulofeu, R; Galdon, G; Giménez-Pérez, G; González-Clemente, JM; Mauricio, D; Mitjavila, J; Ortega, E | 1 |
| Bonazzi, P; Bonfigli, AR; Cenerelli, S; Fumelli, D; Galeazzi, L; Galeazzi, R; Giunta, S; Sirolla, C; Testa, I; Testa, R | 1 |
| Lu, J; Pan, C; Yang, G | 1 |
| Ai, VH; Chow, WS; Lam, KS; O, K; Siow, YL; Tan, KC | 1 |
| Burke, V; Kaye, JM; McCann, VJ; Stanton, KG; Taylor, RR; van Bockxmeer, FM; Vasikaran, SD | 1 |
21 review(s) available for homocysteine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
The efficacy of vitamin B
Topics: Diabetes Mellitus, Type 2; Dietary Supplements; Homocysteine; Humans; Hypoglycemic Agents; Metformin; Peripheral Nervous System Diseases; Vitamin B 12; Vitamin B 12 Deficiency; Vitamins | 2022 |
Effectiveness and Safety of Fufang Danshen Dripping Pill (Cardiotonic Pill) on Blood Viscosity and Hemorheological Factors for Cardiovascular Event Prevention in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis.
Topics: Adiponectin; Blood Viscosity; Cardiotonic Agents; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Homocysteine; Humans | 2023 |
Type 2 diabetes mellitus and cardiovascular risk; what the pharmacotherapy can change through the epigenetics.
Topics: Alarmins; Antihypertensive Agents; Cardiovascular Diseases; Chromatin; Diabetes Mellitus, Type 2; DNA Methylation; Endothelium, Vascular; Epigenesis, Genetic; Extracellular Traps; Gastrointestinal Microbiome; Histones; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Hypoglycemic Agents; Insulin; Metabolic Syndrome; Renin-Angiotensin System; Risk Factors; RNA, Untranslated | 2020 |
Effect of folate supplementation on insulin sensitivity and type 2 diabetes: a meta-analysis of randomized controlled trials.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Dietary Supplements; Fasting; Female; Folic Acid; Glycated Hemoglobin; Homocysteine; Humans; Insulin; Insulin Resistance; Male; Randomized Controlled Trials as Topic; Risk Factors | 2019 |
Effect of the vegetarian diet on non-communicable diseases.
Topics: Blood Platelets; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diet, Vegetarian; Fatty Acids, Omega-3; Feeding Behavior; Homocysteine; Humans; Neoplasms; Vitamin B 12 Deficiency | 2014 |
Association of homocysteine with type 2 diabetes: a meta-analysis implementing Mendelian randomization approach.
Topics: Alleles; Diabetes Mellitus, Type 2; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Mendelian Randomization Analysis; Methylenetetrahydrofolate Reductase (NADPH2); Risk Factors | 2013 |
The role of the one-carbon cycle in the developmental origins of Type 2 diabetes and obesity.
Topics: Adiposity; Carbon Cycle; Diabetes Mellitus, Type 2; Environmental Exposure; Female; Fetal Development; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Infant, Newborn; Insulin Resistance; Male; Maternal Nutritional Physiological Phenomena; Methylmalonic Acid; Obesity; Pregnancy; Prenatal Exposure Delayed Effects; Vitamin B 12; Vitamin B 12 Deficiency | 2014 |
Relationship between homocysteine level and diabetic retinopathy: a systematic review and meta-analysis.
Topics: Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Homocysteine; Humans; Risk Factors | 2014 |
[The assessment of bone quality in lifestyle-related diseases].
Topics: Arginine; Biomarkers; Bone and Bones; Bone Remodeling; Collagen; Diabetes Mellitus, Type 2; Homocysteine; Humans; Hyperhomocysteinemia; Life Style; Lysine; Osteoporosis; Pulmonary Disease, Chronic Obstructive; Renal Insufficiency, Chronic; Risk; Tomography, X-Ray Computed | 2016 |
Is a low blood level of vitamin B12 a cardiovascular and diabetes risk factor? A systematic review of cohort studies.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Meta-Analysis as Topic; Risk Factors; Treatment Outcome; Vitamin B 12; Vitamin B 12 Deficiency | 2011 |
Common variants of homocysteine metabolism pathway genes and risk of type 2 diabetes and related traits in Indians.
Topics: Adult; Blood Glucose; Case-Control Studies; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Genetic Association Studies; Genetic Variation; Homocysteine; Humans; India; Male; Metabolic Networks and Pathways; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Risk Factors | 2012 |
Effect of folic acid supplementation on plasma total homocysteine levels and glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis.
Topics: Aged; Blood Glucose; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dietary Supplements; Female; Folic Acid; Glycated Hemoglobin; Homocysteine; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Vitamin B Complex | 2012 |
[Clinical relevance of homocysteine monitoring in the diabetic patient].
Topics: Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Homocysteine; Humans; Hyperhomocysteinemia; Insulin; Monitoring, Physiologic | 2002 |
[Fibrates: mechanism of action, effect on levels of lipids and risk of coronary events. II. Fenofibrate].
Topics: Adult; Aged; Cholesterol; Coronary Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fenofibrate; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Lipids; Male; Middle Aged; Placebos; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Triglycerides | 2004 |
Coffee consumption and human health--beneficial or detrimental?--Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Cholesterol; Coffee; Diabetes Mellitus, Type 2; Diterpenes; Health Promotion; Homocysteine; Humans; Risk Factors | 2005 |
Homocysteine concentrations in patients with diabetes mellitus--relationship to microvascular and macrovascular disease.
Topics: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Homocysteine; Humans; Insulin; Microcirculation | 2005 |
Cardiovascular risk assessment in type 2 diabetes mellitus.
Topics: Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Homocysteine; Humans; Natriuretic Peptide, Brain; Risk Factors; Smoking | 2006 |
Fenofibrate therapy and cardiovascular protection in diabetes: recommendations after FIELD.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Fenofibrate; Homocysteine; Humans; Hypolipidemic Agents; Lipids; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Treatment Outcome | 2006 |
[Steatosis, chronic hepatitis virus C infection and homocysteine].
Topics: Adult; Animals; Antiviral Agents; Child; Diabetes Mellitus, Type 2; Disease Models, Animal; Drug Resistance, Viral; Fatty Liver; Fatty Liver, Alcoholic; Female; Hepacivirus; Hepatitis C, Chronic; Homocysteine; Humans; Hyperhomocysteinemia; In Vitro Techniques; Insulin Resistance; Interferons; Liver; Liver Cirrhosis; Male; Mice; Mice, Transgenic; Multivariate Analysis; Mutation; Risk Factors | 2007 |
Attenuating cardiovascular risk factors in patients with type 2 diabetes.
Topics: Anticholesteremic Agents; Antihypertensive Agents; Antioxidants; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Lipoproteins; Patient Education as Topic; Risk Factors; Smoking Cessation; Teaching Materials | 2000 |
Oxidative stress and cardiovascular disease in type 2 diabetes: the role of antioxidants and pro-oxidants.
Topics: Antioxidants; Ascorbic Acid; beta Carotene; Blood Glucose; Clinical Trials as Topic; Coronary Artery Disease; Diabetes Mellitus, Type 2; Ferritins; Homocysteine; Humans; Oxidative Stress; Reactive Oxygen Species; Vitamin E | 2002 |
61 trial(s) available for homocysteine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Folic acid effect on homocysteine, sortilin levels and glycemic control in type 2 diabetes mellitus patients.
Topics: Adaptor Proteins, Vesicular Transport; Blood Glucose; Diabetes Mellitus, Type 2; Folic Acid; Glycemic Control; Homocysteine; Humans; Insulin Resistance; Lipids | 2022 |
The effect of apple vinegar consumption on glycemic indices, blood pressure, oxidative stress, and homocysteine in patients with type 2 diabetes and dyslipidemia: A randomized controlled clinical trial.
Topics: Acetic Acid; Adult; Biphenyl Compounds; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Dyslipidemias; Female; Glycemic Index; Homeostasis; Homocysteine; Humans; Insulin; Insulin Resistance; Iran; Male; Malondialdehyde; Malus; Middle Aged; Oxidative Stress; Picrates | 2019 |
Homocysteine as a non-classical risk factor for atherosclerosis in relation to pharmacotherapy of type 2 diabetes mellitus.
Topics: Aged; Aged, 80 and over; Atherosclerosis; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Risk Factors; Waist Circumference | 2017 |
Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
Topics: Adult; Arachidonic Acid; Aspirin; Blood Platelets; Collagen; Coronary Artery Disease; Diabetes Mellitus, Type 2; Drug Resistance; Female; Homocysteine; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Young Adult | 2013 |
Effects of rosiglitazone on serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes mellitus.
Topics: Aged; Aryldialkylphosphatase; Biomarkers; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Homocysteine; Humans; Hypoglycemic Agents; Insulin; Male; Malondialdehyde; Metabolome; Metformin; Middle Aged; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; Triglycerides | 2013 |
Homocysteine, an additional factor, is linked to osteoporosis in postmenopausal women with type 2 diabetes.
Topics: Aged; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Risk Factors | 2014 |
Extreme urinary betaine losses in type 2 diabetes combined with bezafibrate treatment are associated with losses of dimethylglycine and choline but not with increased losses of other osmolytes.
Topics: Adult; Aged; Betaine; Bezafibrate; Choline; Diabetes Mellitus, Type 2; Female; Glycerylphosphorylcholine; Homocysteine; Humans; Hypolipidemic Agents; Inositol; Male; Middle Aged; Sarcosine; Taurine; Young Adult | 2014 |
The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women with Isolated Hypercholesterolemia.
Topics: Adult; Atorvastatin; Bromocriptine; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diet; Dopamine Agonists; Exercise; Female; Fibrinogen; Homocysteine; Humans; Hypercholesterolemia; Hyperprolactinemia; Hypoglycemic Agents; Hypolipidemic Agents; Metformin; Middle Aged; Premenopause; Risk Factors; Uric Acid | 2015 |
Effects of metformin plus gliclazide versus metformin plus glimepiride on cardiovascular risk factors in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Folic Acid; Gliclazide; Glycated Hemoglobin; Homocysteine; Humans; Hypoglycemic Agents; Lipids; Male; Metformin; Middle Aged; Risk Factors; Sulfonylurea Compounds | 2015 |
The effects of alcohol on ambulatory blood pressure and other cardiovascular risk factors in type 2 diabetes: a randomized intervention.
Topics: Aged; Alcohol Drinking; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Heart Rate; Homocysteine; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Wine | 2016 |
Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study.
Topics: Adult; Aged; Anemia; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Vitamin B 12; Vitamin B 12 Deficiency | 2016 |
Effects of two different dialytic treatments on inflammatory markers in people with end-stage renal disease with and without type 2 diabetes mellitus.
Topics: Aged; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Homocysteine; Humans; Inflammation Mediators; Kidney Failure, Chronic; Lipoprotein(a); Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Receptor for Advanced Glycation End Products; Renal Dialysis | 2017 |
Efficacy and safety of a potent and selective peroxisome proliferator activated receptor alpha agonist in subjects with dyslipidemia and type 2 diabetes mellitus.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoprotein B-100; C-Reactive Protein; Cholesterol, HDL; Diabetes Mellitus, Type 2; Double-Blind Method; Dyslipidemias; Female; Fenofibrate; Gemfibrozil; Homocysteine; Humans; Hypolipidemic Agents; Male; Middle Aged; PPAR alpha | 2008 |
Effects of plasma homocysteine levels on serum HTase/PON activity in patients with type 2 diabetes.
Topics: Adult; Aged; Aryldialkylphosphatase; Carboxylic Ester Hydrolases; Diabetes Mellitus, Type 2; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Vitamin B 12; Vitamins | 2008 |
Effect of statins on soluble CD40 ligand in hypercholesterolemic Type 2 diabetic patients.
Topics: Albumins; Biomarkers; Blood Pressure; CD40 Ligand; Diabetes Mellitus, Type 2; Female; Fluorobenzenes; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Interleukin-6; Lipids; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2008 |
Relationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with type 2 diabetes treated with fenofibrate.
Topics: Apolipoprotein A-I; Apolipoprotein A-II; Australia; Biomarkers; Cholesterol, HDL; Creatinine; Diabetes Mellitus, Type 2; Double-Blind Method; Dyslipidemias; Fenofibrate; Finland; Homocysteine; Humans; Hypolipidemic Agents; New Zealand; PPAR alpha; Treatment Outcome | 2009 |
Effect of homocysteine-lowering treatment with folic Acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial.
Topics: Adult; Aged; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Middle Aged; Placebos; Proportional Hazards Models; Risk Factors; Vitamin B 12; Vitamin B 6; Vitamin E | 2009 |
The efficacy of omega-3 fatty acid supplementation on plasma homocysteine and malondialdehyde levels of type 2 diabetic patients.
Topics: Aged; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Fatty Acids, Omega-3; Glycated Hemoglobin; Homocysteine; Humans; Malondialdehyde; Middle Aged | 2010 |
Acute hyperhomocysteinemia impairs endothelium function in subjects with type 2 diabetes mellitus.
Topics: Aged; Blood Glucose; Blood Pressure; Brachial Artery; Cholesterol; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Heart Rate; Homocysteine; Humans; Hyperhomocysteinemia; Luteal Phase; Male; Methionine; Middle Aged; Triglycerides; Vasodilation; Water | 2010 |
Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial.
Topics: Aged; Diabetes Mellitus, Type 2; Female; Folic Acid; Homocysteine; Humans; Hypoglycemic Agents; Long-Term Care; Male; Metformin; Middle Aged; Risk Factors; Vitamin B 12; Vitamin B 12 Deficiency | 2010 |
Can the Mediterranean diet lower HbA1c in type 2 diabetes? Results from a randomized cross-over study.
Topics: Absorptiometry, Photon; Aged; Anthropometry; Biomarkers; Blood Glucose; Blood Pressure; Body Composition; C-Reactive Protein; Carotenoids; Cross-Over Studies; Diabetes Mellitus, Type 2; Diet, Mediterranean; Fatty Acids; Female; Glycated Hemoglobin; Homocysteine; Humans; Lipids; Lutein; Lycopene; Male; Middle Aged; Patient Compliance; Surveys and Questionnaires; Xanthophylls; Zeaxanthins | 2011 |
The effects of tomato consumption on serum glucose, apolipoprotein B, apolipoprotein A-I, homocysteine and blood pressure in type 2 diabetic patients.
Topics: Apolipoprotein A-I; Apolipoproteins B; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Homocysteine; Humans; Male; Middle Aged; Phytotherapy; Plant Extracts; Solanum lycopersicum | 2011 |
Chronologically scheduled snacking with high-protein products within the habitual diet in type-2 diabetes patients leads to a fat mass loss: a longitudinal study.
Topics: Aged; Anthropometry; Biomarkers; Blood Glucose; Body Mass Index; Body Weight; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diet; Dietary Carbohydrates; Dietary Proteins; Energy Intake; Feeding Behavior; Female; Glycated Hemoglobin; Glycemic Index; Homocysteine; Humans; Insulin; Longitudinal Studies; Male; Middle Aged; Postprandial Period; Triglycerides; Weight Loss | 2011 |
Effect of folic acid supplementation on homocysteine, serum total antioxidant capacity, and malondialdehyde in patients with type 2 diabetes mellitus.
Topics: Administration, Oral; Aged; Antioxidants; Diabetes Mellitus, Type 2; Dietary Supplements; Dose-Response Relationship, Drug; Double-Blind Method; Folic Acid; Homocysteine; Humans; Male; Malondialdehyde; Metformin; Middle Aged; Oxidative Stress; Vitamin B 12 | 2011 |
Effects of raloxifene on lipid and bone metabolism in postmenopausal women with type 2 diabetes.
Topics: Aged; Alkaline Phosphatase; Biomarkers; Blood Glucose; Bone and Bones; Bone Density Conservation Agents; Cholesterol, LDL; Collagen Type I; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Male; Middle Aged; Peptides; Postmenopause; Raloxifene Hydrochloride | 2013 |
L-arginine infusion decreases plasma total homocysteine concentrations through increased nitric oxide production and decreased oxidative status in Type II diabetic patients.
Topics: Arginine; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Homocysteine; Humans; Infusions, Intravenous; Male; Middle Aged; Nitrates; Nitric Oxide; Nitrites; Osmolar Concentration; Oxidative Stress; Reference Values; Sulfhydryl Compounds | 2002 |
Improved insulin sensitivity and metabolic control in type 2 diabetes does not influence plasma homocysteine.
Topics: Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Homocysteine; Humans; Hypoglycemic Agents; Injections, Intravenous; Insulin; Middle Aged; Obesity | 2003 |
Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes.
Topics: Acetylcholine; Antioxidants; Apolipoprotein A-I; Area Under Curve; Blood Circulation; Blood Pressure; Bradykinin; Cholesterol, HDL; Cholesterol, LDL; Coenzymes; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Enzyme Inhibitors; F2-Isoprostanes; Female; Fenofibrate; Forearm; Glycated Hemoglobin; Homocysteine; Humans; Hypolipidemic Agents; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Statistics as Topic; Systole; Treatment Outcome; Triglycerides; Ubiquinone; Vasodilator Agents | 2003 |
Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: a one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factors.
Topics: Blood Glucose; Blood Pressure; Carbamates; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Homocysteine; Humans; Hypoglycemic Agents; Lipoprotein(a); Male; Middle Aged; Piperidines; Plasminogen Activator Inhibitor 1; Risk Factors; Sulfonylurea Compounds; Time Factors; Treatment Outcome | 2003 |
Plasma homocysteine and S-adenosylmethionine in erythrocytes as determinants of carotid intima-media thickness: different effects in diabetic and non-diabetic individuals. The Hoorn Study.
Topics: Aged; Arteriosclerosis; Carotid Arteries; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Erythrocytes; Female; Homocysteine; Humans; Male; Middle Aged; S-Adenosylmethionine; Tunica Intima; Tunica Media; Vitamin B 12; Vitamin B 6 | 2003 |
High plasma homocysteine concentrations are associated with plasma concentrations of thrombomodulin in patients with type 2 diabetes and link diabetic nephropathy to macroangiopathy.
Topics: Aged; Blood Glucose; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Endothelium, Vascular; Female; Homocysteine; Humans; Male; Middle Aged; Regression Analysis; Thrombomodulin | 2003 |
Effect of fenofibrate-mediated increase in plasma homocysteine on the progression of coronary artery disease in type 2 diabetes mellitus.
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Female; Fenofibrate; Homocysteine; Humans; Hypolipidemic Agents; Male; Middle Aged | 2004 |
Metabolic effects of orally administered amino acid mixture in elderly subjects with poorly controlled type 2 diabetes mellitus.
Topics: Aged; Aged, 80 and over; Amino Acids, Essential; Blood Glucose; Cholesterol; Cholesterol, HDL; Creatinine; Cross-Over Studies; Diabetes Mellitus, Type 2; Dietary Proteins; Dietary Supplements; Female; Glycated Hemoglobin; Homocysteine; Humans; Male; Treatment Outcome; Triglycerides | 2004 |
Natural honey lowers plasma glucose, C-reactive protein, homocysteine, and blood lipids in healthy, diabetic, and hyperlipidemic subjects: comparison with dextrose and sucrose.
Topics: Adult; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Glucose; Homocysteine; Honey; Humans; Hyperlipidemias; Hypoglycemic Agents; Hypolipidemic Agents; Lipids; Male; Middle Aged; Sucrose | 2004 |
The effect of oral folic acid on glutathione, glycaemia and lipids in Type 2 diabetes.
Topics: Adult; Aged; Albuminuria; Blood Glucose; Blood Pressure; Cholesterol, HDL; Diabetes Mellitus, Type 2; Dietary Supplements; Erythrocytes; Female; Folic Acid; Glutathione; Glycated Hemoglobin; Homocysteine; Humans; Hypoglycemic Agents; Lipids; Male; Metformin; Middle Aged; Triglycerides; Vitamin B 6 | 2004 |
Metabolic variations with oral antidiabetic drugs in patients with Type 2 diabetes: comparison between glimepiride and metformin.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Female; Food; Glycated Hemoglobin; Homocysteine; Humans; Hypoglycemic Agents; Lipoprotein(a); Male; Metformin; Middle Aged; Plasminogen Activator Inhibitor 1; Sulfonylurea Compounds | 2004 |
S-adenosylmethionine and 5-methyltetrahydrofolate are associated with endothelial function after controlling for confounding by homocysteine: the Hoorn Study.
Topics: Aged; Brachial Artery; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Nitroglycerin; Regional Blood Flow; Risk Factors; S-Adenosylmethionine; Tetrahydrofolates; Ultrasonography; Vasodilation; Vasodilator Agents; Vitamin B 12; Vitamin B 6 | 2005 |
The effect of improved post-prandial blood glucose control on post-prandial metabolism and markers of vascular risk in people with Type 2 diabetes.
Topics: Aged; Blood Glucose; Blood Glucose Self-Monitoring; Body Mass Index; Cholesterol; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Female; Homocysteine; Humans; Hypoglycemic Agents; Insulin; Insulin Aspart; Lipoproteins; Male; Postprandial Period; Risk Factors | 2005 |
Short-term oral folic acid supplementation enhances endothelial function in patients with type 2 diabetes.
Topics: Acetylcholine; Administration, Oral; Blood Flow Velocity; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Endothelium, Vascular; Female; Folic Acid; Forearm; Homocysteine; Humans; Male; Middle Aged; Osmolar Concentration; Pulse; Regional Blood Flow; Vasodilation; Vasodilator Agents | 2005 |
Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Body Mass Index; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Fenofibrate; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Homocysteine; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Incidence; Male; Middle Aged; Models, Biological; Smoking; Treatment Outcome | 2005 |
Does metformin decrease blood pressure in patients with Type 2 diabetes intensively treated with insulin?
Topics: Age Factors; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Body Mass Index; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Female; Glycated Hemoglobin; Heart Rate; Homocysteine; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Time Factors | 2005 |
The effect of rosiglitazone on novel atherosclerotic risk factors in patients with type 2 diabetes mellitus and hypertension. An open-label observational study.
Topics: Aged; Arteriosclerosis; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Homocysteine; Humans; Hypertension; Hypoglycemic Agents; Lipoprotein(a); Male; Middle Aged; Risk Factors; Risk Reduction Behavior; Rosiglitazone; Thiazolidinediones | 2005 |
Total plasma homocysteine and arteriosclerotic outcomes in type 2 diabetes with nephropathy.
Topics: Aged; Amlodipine; Antihypertensive Agents; Arteriosclerosis; Biphenyl Compounds; Cardiovascular System; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Double-Blind Method; Female; Homocysteine; Humans; Irbesartan; Male; Middle Aged; Placebos; Risk Factors; Smoking; Tetrazoles; Treatment Outcome | 2005 |
[Effect of n-3 polyunsaturated fatty acids on plasma lipid, LDL lipoperoxidation, homocysteine and inflammation indicators in diabetic dyslipidemia treated with statin + fibrate combination].
Topics: Adult; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Fenofibrate; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Inflammation Mediators; Lipid Peroxidation; Lipids; Lipoproteins, LDL; Male; Middle Aged; Pravastatin; Single-Blind Method | 2005 |
The metabolic response to a high-protein, low-carbohydrate diet in men with type 2 diabetes mellitus.
Topics: Aged; Aged, 80 and over; Aldosterone; Diabetes Mellitus, Type 2; Diet, Carbohydrate-Restricted; Dietary Carbohydrates; Dietary Proteins; Homocysteine; Human Growth Hormone; Humans; Hydrocortisone; Insulin-Like Growth Factor I; Male; Middle Aged; Thyrotropin; Thyroxine; Triiodothyronine | 2006 |
Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Homocysteine; Humans; Hypoglycemic Agents; Insulin; Male; Metabolic Syndrome; Metformin; Middle Aged; Pioglitazone; Rosiglitazone; Thiazolidinediones | 2006 |
Folic acid improves endothelial dysfunction in type 2 diabetes--an effect independent of homocysteine-lowering.
Topics: Brachial Artery; C-Reactive Protein; Cross-Over Studies; Diabetes Mellitus, Type 2; Dietary Supplements; Endothelium, Vascular; Fasting; Female; Folic Acid; Homocysteine; Humans; Inflammation; Male; Middle Aged; Nitroglycerin; Vasodilation; Vasodilator Agents | 2006 |
Sildenafil citrate diminishes microalbuminuria and the percentage of A1c in male patients with type 2 diabetes.
Topics: Adult; Albuminuria; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Double-Blind Method; Glycated Hemoglobin; Homocysteine; Humans; Male; Middle Aged; Piperazines; Placebos; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2007 |
[Effects of intervention therapy of methylcobalamin and folic acid on plasma homocysteine concentration and homocysteine thiolactonases/paraoxonase activity in patients with type 2 diabetes mellitus].
Topics: Administration, Oral; Adult; Aged; Aryldialkylphosphatase; Carboxylic Ester Hydrolases; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Folic Acid; Homocysteine; Humans; Injections, Intramuscular; Middle Aged; Treatment Outcome; Vitamin B 12; Vitamin B Complex | 2007 |
Type 2 diabetes: assessment of endothelial lesion and fibrinolytic system markers.
Topics: Biomarkers; Diabetes Complications; Diabetes Mellitus, Type 2; Endothelial Cells; Endothelium, Vascular; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Homocysteine; Humans; Hypertension; Male; Middle Aged; Plasminogen Activator Inhibitor 1; von Willebrand Factor | 2007 |
Long-term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus.
Topics: Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Fenofibrate; Homocysteine; Humans; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, VLDL; Male; Middle Aged; Placebos | 2007 |
Folate administration reduces circulating homocysteine levels in NIDDM patients on long-term metformin treatment.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dipeptides; Double-Blind Method; Female; Folic Acid; Hematinics; Homocysteine; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome; Vitamin B 12 | 1998 |
Total homocysteine is associated with nephropathy in non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; Albuminuria; Cystathionine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Kidney Function Tests; Male; Methylmalonic Acid; Middle Aged; Regression Analysis; Vitamins | 1999 |
Nutritionally complete prepared meal plan to reduce cardiovascular risk factors: a randomized clinical trial.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Cholesterol; Diabetes Mellitus, Type 2; Diet; Female; Glycated Hemoglobin; Homocysteine; Humans; Hyperlipidemias; Hypertension; Insulin; Male; Middle Aged; Nutritive Value; Patient Compliance; Risk Factors; Treatment Outcome; Weight Loss | 1999 |
Serum homocysteine, MTHFR gene polymorphism, and carotid intimal-medial thickness in NIDDM subjects.
Topics: Arteriosclerosis; Carotid Artery, Common; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Predictive Value of Tests; Regression Analysis; Risk Factors; Tunica Intima; Tunica Media; Ultrasonography | 1999 |
Increased dietary micronutrients decrease serum homocysteine concentrations in patients at high risk of cardiovascular disease.
Topics: Adult; Aged; Analysis of Variance; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diet; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Pyridoxine; Risk Factors; Vitamin B 12 | 1999 |
Total plasma homocysteine and insulin levels in type 2 diabetic patients with secondary failure to oral agents.
Topics: Administration, Oral; Aged; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Hypoglycemic Agents; Insulin; Male | 1999 |
Glycemia, MTHFR genotype and low homocysteine in uncomplicated type 2 diabetic patients.
Topics: Adult; Diabetes Mellitus, Type 2; Female; Gene Frequency; Homocysteine; Humans; Hyperglycemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Reference Values | 2000 |
Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects.
Topics: Aged; Apolipoprotein B-100; Apolipoproteins B; Blood Glucose; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Diabetes Mellitus, Type 2; Dietary Proteins; Dietary Supplements; Double-Blind Method; Fasting; Female; Homocysteine; Humans; Insulin; Lipids; Male; Middle Aged; Placebos; Risk Factors; Soybean Proteins; Triglycerides | 2001 |
Hyperhomocysteinemia in poorly controlled type 2 diabetes patients.
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glycated Hemoglobin; Homocysteine; Humans; Hyperhomocysteinemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Risk Factors | 2000 |
Increasing homocysteine levels and diabetic autonomic neuropathy.
Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension, Renal; Logistic Models; Male; Middle Aged; Prospective Studies; Risk Factors | 2001 |
256 other study(ies) available for homocysteine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Homocysteine inhibits pro-insulin receptor cleavage and causes insulin resistance via protein cysteine-homocysteinylation.
Topics: Adipose Tissue; Animals; Antigens, CD; CHO Cells; Cricetulus; Diabetes Mellitus, Type 2; Disease Models, Animal; Furin; HEK293 Cells; Hep G2 Cells; Homocysteine; Humans; Hyperhomocysteinemia; Insulin Resistance; Liver; Male; Mice, Inbred C57BL; Muscle, Skeletal; Protein Processing, Post-Translational; Rats; Receptor, Insulin | 2021 |
Associations between homocysteine, inflammatory cytokines and sarcopenia in Chinese older adults with type 2 diabetes.
Topics: Aged; China; Cross-Sectional Studies; Cytokines; Diabetes Mellitus, Type 2; Hand Strength; Homocysteine; Humans; Sarcopenia | 2021 |
Plasma homocysteine is associated with nonproliferative retinopathy in patients with type 2 diabetes without renal disease.
Topics: Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Folic Acid; Homocysteine; Humans; Vitamin B 12 | 2022 |
Associations of Homocysteine with B Vitamins and Zinc in Serum Levels of Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study.
Topics: Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Folic Acid; Homocysteine; Humans; Male; Vitamin B 12; Vitamin B Complex; Zinc | 2021 |
Preference between serum homocysteine and urinary periostin as early predictive biomarkers of renal dysfunction among uncontrolled diabetics.
Topics: Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Homocysteine; Humans | 2022 |
Does Metformin Treatment in Pediatric Population Cause Vitamin B12 Deficiency?
Topics: Adolescent; Child; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Male; Metabolic Syndrome; Metformin; Methylmalonic Acid; Prospective Studies; Transcobalamins; Vitamin B 12; Vitamin B 12 Deficiency | 2022 |
Quantitative phosphoproteomics reveals diverse stimuli activate distinct signaling pathways during neutrophil activation.
Topics: Diabetes Mellitus, Type 2; Glucose; Homocysteine; Humans; Hyperglycemia; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Neutrophil Activation; Neutrophils; Protein Serine-Threonine Kinases; Signal Transduction | 2022 |
Nutritional biomarkers and heart failure requiring hospitalization in patients with type 2 diabetes: the SURDIAGENE cohort.
Topics: Aged; Betaine; Biomarkers; Carnitine; Choline; Cohort Studies; Cysteine; Diabetes Mellitus, Type 2; Female; Heart Failure; Homocysteine; Hospitalization; Humans; Male; Methionine; Middle Aged; Prospective Studies; Risk Factors | 2022 |
Homocysteine Metabolism Pathway Is Involved in the Control of Glucose Homeostasis: A Cystathionine Beta Synthase Deficiency Study in Mouse.
Topics: Animals; Cystathionine beta-Synthase; Diabetes Mellitus, Type 2; Glucose; Homeostasis; Homocysteine; Homocystinuria; Hyperhomocysteinemia; Mice | 2022 |
Association Between Serum Homocysteine Levels and Severity of Diabetic Kidney Disease in 489 Patients with Type 2 Diabetes Mellitus: A Single-Center Study.
Topics: Albuminuria; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Homocysteine; Humans; Renal Insufficiency, Chronic | 2022 |
Circulating level of homocysteine contributes to diabetic retinopathy associated with dysregulated lipid profile and impaired kidney function in patients with type 2 diabetes mellitus.
Topics: Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Homocysteine; Humans; Kidney | 2023 |
The Association of Homocysteine and Diabetic Retinopathy in Homocysteine Cycle in Chinese Patients With Type 2 Diabetes.
Topics: Asian People; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Homocysteine; Humans; Methionine; Risk Factors | 2022 |
A Retrospective Study on the Time in Range of Blood Glucose and Type 2 Diabetic Peripheral Neuropathy.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Glycated Hemoglobin; Homocysteine; Humans; Retrospective Studies | 2022 |
Factors associated with higher falling risk in elderly diabetic patients with lacunar stroke.
Topics: Accidental Falls; Aged; Blood Glucose; Blood Glucose Self-Monitoring; China; Diabetes Mellitus, Type 2; Disease Susceptibility; Homocysteine; Humans; Risk Factors; Stroke, Lacunar | 2022 |
Effect of Leptin Levels of Type 2 Diabetes Mellitus and Diabetic Complications.
Topics: Albumins; Biomarkers; Body Mass Index; Cholesterol, HDL; Cystatin C; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Estradiol; Female; Homocysteine; Humans; Leptin; Male; Polyesters; Testosterone; Triglycerides | 2022 |
Association of Serum Homocysteine with Cardiovascular and All-Cause Mortality in Adults with Diabetes: A Prospective Cohort Study.
Topics: Adult; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Homocysteine; Humans; Neoplasms; Nutrition Surveys; Prospective Studies; Risk Factors | 2022 |
Untargeted metabolomic analysis of aqueous humor in diabetic macular edema.
Topics: Antioxidants; Aqueous Humor; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Fatty Acids; Glucose; Homocysteine; Homovanillic Acid; Humans; Inflammation; Macular Edema; Prostaglandins; Sorbitol | 2022 |
Relationship between plasma homocysteine and chronic kidney disease in US patients with type 2 diabetes mellitus: a cross-sectional study.
Topics: Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Homocysteine; Humans; Hyperhomocysteinemia; Male; Nutrition Surveys; Renal Insufficiency, Chronic | 2022 |
The association of homocysteine level with the risk of diabetic nephropathy and diabetic retinopathy in NHANES.
Topics: Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Homocysteine; Humans; Kidney Function Tests; Nutrition Surveys; Risk Factors | 2023 |
The Associations of Habitual Intake of Sulfur Amino Acids, Proteins and Diet Quality with Plasma Sulfur Amino Acid Concentrations: The Maastricht Study.
Topics: Amino Acids, Sulfur; Cardiovascular Diseases; Cross-Sectional Studies; Cystathionine; Cysteine; Diabetes Mellitus, Type 2; Diet; Female; Homocysteine; Humans; Methionine; Obesity; Taurine | 2023 |
Bacteroides ovatus accelerates metformin-induced vitamin B12 deficiency in type 2 diabetes patients by accumulating cobalamin.
Topics: Animals; Diabetes Mellitus, Type 2; Homocysteine; Humans; Metformin; Mice; Vitamin B 12; Vitamin B 12 Deficiency | 2023 |
Value of Hcy combined with Framingham score for predicting macrovascular disease in elderly patients with type 2 diabetes.
Topics: Aged; Blood Glucose; Cerebrovascular Disorders; Cholesterol; Diabetes Mellitus, Type 2; Homocysteine; Humans; Retrospective Studies; Risk Factors | 2023 |
S-Homocysteinylation effects on transthyretin: worsening of cardiomyopathy onset.
Topics: Amyloid Neuropathies, Familial; Cardiomyopathies; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Homocysteine; Humans; Methionine; Mutation; Myocytes, Cardiac; Prealbumin; Protein Conformation; Protein Stability; Stroke; Structure-Activity Relationship | 2020 |
Association between serum homocysteine level and cognitive function in middle-aged type 2 diabetes mellitus patients.
Topics: Adult; Case-Control Studies; Cognitive Dysfunction; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Indonesia; Male; Middle Aged; Neuropsychological Tests; Risk Factors; Surveys and Questionnaires | 2019 |
Association between metformin dose and vitamin B12 deficiency in patients with type 2 diabetes.
Topics: Age Factors; Aged; Alcohol Drinking; Anemia; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Folic Acid; Homocysteine; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Odds Ratio; Republic of Korea; Time Factors; Vitamin B 12; Vitamin B 12 Deficiency; Vitamins | 2019 |
Relationship between metformin use and vitamin B
Topics: Aged; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Erythrocyte Indices; Female; Hemoglobins; Homocysteine; Humans; Hypoglycemic Agents; Japan; Male; Metformin; Middle Aged; Nutritional Status; Vitamin B 12; Vitamin B 12 Deficiency | 2020 |
A compound reflects the level of homocysteine based on Rhodamine B and its ability to respond to homocysteine in the plasma of diabetic patients.
Topics: Blood Viscosity; Case-Control Studies; Diabetes Mellitus, Type 2; Fluorescent Dyes; Homocysteine; Humans; Hydrogen-Ion Concentration; Middle Aged; Molecular Structure; Reproducibility of Results; Rhodamines; Spectrometry, Fluorescence; Viscosity | 2020 |
Relationship between plasma total homocysteine and the severity of renal function in Chinese patients with type 2 diabetes mellitus aged ≥75 years.
Topics: Age Factors; Aged; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Homocysteine; Humans; Kidney; Male; Middle Aged; Risk Factors; Severity of Illness Index | 2020 |
Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson's disease patients with type 2 diabetes mellitus.
Topics: Age Factors; Aged; Biomarkers; Blood Glucose; China; Cholesterol, LDL; Dementia; Diabetes Mellitus, Type 2; Female; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Inflammation; Male; Middle Aged; Parkinson Disease; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Vascular Diseases | 2020 |
Vitamin D Provides Benefit Based on the Proinflammatory Effects of Homocysteine in Elderly Patients With Type 2 Diabetes Mellitus.
Topics: Aged; Aged, 80 and over; Antigens, CD19; CD8-Positive T-Lymphocytes; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Lymphocyte Count; Lymphocyte Subsets; Male; Middle Aged; Retrospective Studies; Vitamin D; Vitamins | 2020 |
Changes and Risk Factors of Skeletal Muscle Mass and Strength in Patients with Type 2 Diabetes over 60 Years Old: A Cross-Sectional Study from China.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Age Factors; Aged; Biomarkers; Body Composition; Case-Control Studies; China; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Hand Strength; Homocysteine; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Muscle, Skeletal; Oxidative Stress; Risk Assessment; Risk Factors; Sarcopenia | 2020 |
The relationship between exacerbated diabetic peripheral neuropathy and metformin treatment in type 2 diabetes mellitus.
Topics: Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Homocysteine; Humans; Male; Metformin; Methylmalonic Acid; Middle Aged; Peripheral Nervous System Diseases; Risk Factors; Vitamin B 12 | 2021 |
PECULIARITIES OF CHANGES IN HOMOCYSTEINE LEVELS DEPENDING ON VITAMIN STATUS IN PATIENTS WITH CHRONIC PANCREATITIS AND TYPE 2 DIABETES.
Topics: Diabetes Mellitus, Type 2; Folic Acid; Homocysteine; Humans; Pancreatitis, Chronic; Vitamin B 12 | 2021 |
Alteration of intrapancreatic serotonin, homocysteine, TNF-α, and NGF levels as predisposing factors for diabetes following exposure to 900-MHz waves.
Topics: Animals; Biomarkers; Cell Phone; Diabetes Mellitus, Type 2; Electromagnetic Fields; Homocysteine; Iran; Male; Nerve Growth Factor; Pancreas; Radio Waves; Rats; Rats, Sprague-Dawley; Serotonin; Tumor Necrosis Factor-alpha | 2021 |
Elevated Plasma Homocysteine Level Associated with Further Left Ventricular Structure and Function Damages in Type 2 Diabetic Patients: A Three-Dimensional Speckle Tracking Echocardiography Study.
Topics: Aged; Diabetes Mellitus, Type 2; Echocardiography; Female; Heart Ventricles; Homocysteine; Humans; Hyperhomocysteinemia; Imaging, Three-Dimensional; Male; Middle Aged; Ventricular Dysfunction, Left; Ventricular Remodeling | 2021 |
Association between plasma homocysteine levels and pancreatic islet beta-cell function in the patients with type 2 diabetes mellitus: a cross-sectional study from China.
Topics: Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Homocysteine; Humans; Insulin Resistance; Islets of Langerhans | 2021 |
Plasma homocysteine levels are associated with macular thickness in type 2 diabetes without diabetic macular edema.
Topics: Adult; Aged; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Folic Acid; Homocysteine; Humans; Macula Lutea; Macular Edema; Male; Middle Aged; Regression Analysis; Vitamin B 12 | 2018 |
Synergistic Effect of the
Topics: Aged; Asian People; Brain Ischemia; Case-Control Studies; China; Diabetes Mellitus, Type 2; Epoxide Hydrolases; Female; Genetic Predisposition to Disease; Glycated Hemoglobin; Haplotypes; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Risk; Stroke | 2017 |
Increased Plasma Homocysteine Level is Associated with Executive Dysfunction in Type 2 Diabetic Patients with Mild Cognitive Impairment.
Topics: Cognitive Dysfunction; Cystathionine beta-Synthase; Diabetes Mellitus, Type 2; Executive Function; Female; Gene Frequency; Genotype; Homocysteine; Humans; Logistic Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Neuropsychological Tests; Polymorphism, Single Nucleotide; Severity of Illness Index | 2017 |
Association between insulin resistance and total plasma homocysteine levels in type 2 diabetes mellitus patients in south west Nigeria.
Topics: Adult; Aged; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Homocysteine; Humans; Insulin Resistance; Lipids; Male; Middle Aged | 2017 |
Plasma homocysteine and cerebral small vessel disease as possible mediators between kidney and cognitive functions in patients with diabetes mellitus.
Topics: Aged; Aged, 80 and over; Biomarkers; Cerebral Small Vessel Diseases; Cognition; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Odds Ratio; Prognosis | 2017 |
Relation of four nontraditional lipid profiles to diabetes in rural Chinese H-type hypertension population.
Topics: Aged; Area Under Curve; Asian People; Biomarkers; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Fasting; Female; Homocysteine; Humans; Hypertension; Male; Middle Aged; ROC Curve; Rural Population; Triglycerides | 2017 |
Serum Homocysteine and its Association with Glycemic Control in Type 2 Diabetic Patients.
Topics: Bangladesh; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Male; Risk Factors | 2017 |
Considerations for automated machine learning in clinical metabolic profiling: Altered homocysteine plasma concentration associated with metformin exposure.
Topics: Bias; Body Mass Index; Case-Control Studies; Computational Biology; Diabetes Mellitus, Type 2; Homocysteine; Humans; Hypoglycemic Agents; Metabolome; Metabolomics; Metformin; Risk Factors; Supervised Machine Learning; Translational Research, Biomedical | 2018 |
Inverse association between plasma homocysteine concentrations and type 2 diabetes mellitus among a middle-aged and elderly Chinese population.
Topics: Age Factors; Aged; Aged, 80 and over; Alcohol Drinking; Biomarkers; Blood Glucose; China; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Prevalence; Risk Assessment; Risk Factors | 2018 |
FEATURES OF EXCRETION OF MELATONIN IN URINE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND NON-ALCOHOLIC FATTY LIVER DISEASE WITH MANIFESTATIONS OF FIBROSIS AND ITS RELATIONSHIP WITH CERTAIN METABOLIC AND IMMUNOLOGICAL INDICATORS.
Topics: Adolescent; Adult; Albuminuria; Biomarkers; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cohort Studies; Diabetes Mellitus, Type 2; Elasticity Imaging Techniques; Female; Homocysteine; Humans; Liver Cirrhosis; Male; Melatonin; Middle Aged; Non-alcoholic Fatty Liver Disease | 2018 |
Association of
Topics: Aged; Alleles; Case-Control Studies; China; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Epoxide Hydrolases; Female; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Haplotypes; Homocysteine; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide | 2018 |
Single-marker and multi-marker approaches to appraise the relationships between biomarkers and microalbuminuria in Chinese middle-aged and elderly from communities: a cross-sectional analysis.
Topics: Aged; Aged, 80 and over; Albuminuria; Biomarkers; C-Reactive Protein; China; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Risk Factors; Smoking; Uric Acid | 2018 |
Genetically elevated circulating homocysteine concentrations increase the risk of diabetic kidney disease in Chinese diabetic patients.
Topics: Asian People; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Follow-Up Studies; Genetic Predisposition to Disease; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Prognosis; Risk Factors | 2019 |
Hyperhomocysteinemia promotes insulin resistance by inducing endoplasmic reticulum stress in adipose tissue.
Topics: Adipocytes; Adipose Tissue; Animals; Cytokines; Diabetes Mellitus, Type 2; Endoplasmic Reticulum; Glucose; Homocysteine; Hyperhomocysteinemia; Immunohistochemistry; Inflammation; Insulin; Insulin Resistance; Macrophages; Macrophages, Peritoneal; Male; MAP Kinase Kinase 4; Mice; Mice, Inbred C57BL; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled | 2013 |
Association between osteoprotegerin, fetuin-A, carotid intima media thickness, and urinary albumin excretion in Type 2 diabetes.
Topics: Aged; Albuminuria; alpha-2-HS-Glycoprotein; Biomarkers; C-Reactive Protein; Carotid Intima-Media Thickness; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Male; Middle Aged; Osteoprotegerin | 2013 |
Higher homocysteine and lower betaine increase the risk of microangiopathy in patients with diabetes mellitus carrying the GG genotype of PEMT G774C.
Topics: Adult; Aged; Aged, 80 and over; Betaine; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Genotype; Homocysteine; Humans; Male; Middle Aged; Odds Ratio; Phosphatidylethanolamine N-Methyltransferase; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide | 2013 |
Erythrocyte glutathione transferase activity: a possible early biomarker for blood toxicity in uremic diabetic patients.
Topics: Adult; Aged; Biomarkers; Catalase; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Erythrocytes; Female; Glutathione Transferase; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Uremia | 2014 |
Relationship between metformin use, vitamin B12 deficiency, hyperhomocysteinemia and vascular complications in patients with type 2 diabetes.
Topics: Aged; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Dietary Supplements; Dose-Response Relationship, Drug; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypoglycemic Agents; Japan; Male; Metformin; Middle Aged; Prevalence; Risk Factors; Severity of Illness Index; Stroke; Vitamin B 12; Vitamin B 12 Deficiency | 2013 |
Homocysteine is linked to macular edema in type 2 diabetes.
Topics: Adult; Aged; Biomarkers; China; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Disease Progression; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Homocysteine; Humans; Immunoassay; Incidence; Macular Edema; Male; Middle Aged; Nephelometry and Turbidimetry; Prognosis; Prospective Studies; Retina; Risk Factors; Surveys and Questionnaires | 2014 |
Relation of asymmetric dimethylarginine levels to macrovascular disease and inflammation markers in type 2 diabetic patients.
Topics: Aged; Arginine; Atherosclerosis; Biomarkers; Blood Sedimentation; C-Reactive Protein; Carotid Intima-Media Thickness; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Homocysteine; Humans; Inflammation Mediators; Male; Middle Aged; Regression Analysis; Systemic Vasculitis; Up-Regulation | 2014 |
Vitamin status as a determinant of serum homocysteine concentration in type 2 diabetic retinopathy.
Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Odds Ratio; Prevalence; Regression Analysis; Risk Factors; Vitamin B 12; Vitamins | 2014 |
A modified portfolio diet complements medical management to reduce cardiovascular risk factors in diabetic patients with coronary artery disease.
Topics: Aged; Biomarkers; Blood Glucose; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Dietary Fats; Dietary Fiber; Energy Intake; Female; Homocysteine; Humans; Male; Middle Aged; Motor Activity; Patient Compliance; Pilot Projects; Risk Factors; Soybean Proteins | 2015 |
Associations of common variants in methionine metabolism pathway genes with plasma homocysteine and the risk of type 2 diabetes in Han Chinese.
Topics: Adult; Aged; Alleles; Case-Control Studies; China; Diabetes Mellitus, Type 2; Female; Genetic Markers; Genetic Variation; Genotype; Haplotypes; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Phosphatidylethanolamine N-Methyltransferase; Polymorphism, Single Nucleotide | 2014 |
Homocysteine, cysteine, folate and vitamin B₁₂ status in type 2 diabetic patients with chronic kidney disease.
Topics: Aged; Aged, 80 and over; Biomarkers; Chromatography, High Pressure Liquid; Cysteine; Diabetes Mellitus, Type 2; Disease Progression; Female; Folic Acid; Homocysteine; Humans; Male; Renal Insufficiency, Chronic; Vitamin B 12 | 2015 |
Association of tagging SNPs in the MTHFR gene with risk of type 2 diabetes mellitus and serum homocysteine levels in a Chinese population.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Haplotypes; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide | 2014 |
Association between irisin and homocysteine in euglycemic and diabetic subjects.
Topics: Adult; Aged; Analysis of Variance; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Fasting; Female; Fibronectins; Homocysteine; Humans; Insulin; Lipids; Male; Middle Aged | 2014 |
Homocysteine, cortisol, diabetes mellitus, and psychopathology.
Topics: Aged; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Hydrocortisone; Linear Models; Male; Middle Aged; Predictive Value of Tests; Psychiatric Status Rating Scales; Psychometrics; Psychopathology; Psychotic Disorders; Surveys and Questionnaires | 2015 |
Assessing of oxidative stress related parameters in diabetes mellitus type 2: cause excessive damaging to DNA and enhanced homocysteine in diabetic patients.
Topics: Antioxidants; Diabetes Mellitus, Type 2; DNA Damage; Female; Homocysteine; Humans; Lipid Peroxidation; Male; Oxidative Stress | 2015 |
Serum haematological and biochemical indices of oxidative stress and their relationship with DNA damage and homocysteine in Pakistani type II diabetic patients.
Topics: Adolescent; Adult; Alanine Transaminase; Aspartate Aminotransferases; Blood Sedimentation; Case-Control Studies; Cholesterol; Comet Assay; Creatinine; Diabetes Mellitus, Type 2; DNA Damage; Female; Glycated Hemoglobin; Hematocrit; Homocysteine; Humans; Male; Oxidative Stress; Pakistan; Prospective Studies; Serum Albumin; Triglycerides; Urea; Young Adult | 2015 |
Electrocardiogram Derived QRS Duration >120 ms is Associated With Elevated Plasma Homocysteine Levels in a Rural Australian Cross-Sectional Population.
Topics: Age Factors; Aged; Australia; Body Mass Index; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Electrocardiography; Exercise; Female; Homocysteine; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Retrospective Studies; Risk Factors; Rural Population; Sex Factors; Smoking | 2015 |
Diabetic neuropathy is not associated with homocysteine, folate, vitamin B12 levels, and MTHFR C677T mutation in type 2 diabetic outpatients taking metformin.
Topics: Adult; Aged; Aged, 80 and over; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Folic Acid; Follow-Up Studies; Genotype; Homocysteine; Humans; Hypoglycemic Agents; Male; Metformin; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Outpatients; Prognosis; Vitamin B 12 | 2016 |
H-Type hypertension, stroke and diabetes in China: Opportunities for primary prevention.
Topics: China; Diabetes Mellitus, Type 2; Folic Acid; Homocysteine; Humans; Hypertension; Stroke; Vitamin B Complex | 2016 |
High red blood cell folate is associated with an increased risk of death among adults with diabetes, a 15-year follow-up of a national cohort.
Topics: Aged; Cause of Death; Cerebrovascular Disorders; Cohort Studies; Cotinine; Diabetes Mellitus, Type 2; Dietary Supplements; Dose-Response Relationship, Drug; Erythrocytes; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Nutrition Surveys; Proportional Hazards Models; Risk Factors; Socioeconomic Factors; Vitamin B 12 | 2015 |
[C677T AND A1298C ALLELE POLYMORPHISM GENE OF METHYLENETETRAHYDRAFOLATEREDUCTASE IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE AND TYPE 2 DIABETES].
Topics: Alleles; Case-Control Studies; Diabetes Mellitus, Type 2; Gene Expression; Genotype; Heterozygote; Homocysteine; Homozygote; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Non-alcoholic Fatty Liver Disease; Polymorphism, Single Nucleotide | 2015 |
Non-Alcoholic Fatty Liver Disease Is a Risk Factor for the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus.
Topics: Adult; Aged; Albuminuria; Comorbidity; Cytokines; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fatty Acids, Nonesterified; Female; Glomerular Filtration Rate; GPI-Linked Proteins; Homocysteine; Humans; Incidence; Insulin Resistance; Lectins; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Retrospective Studies; Risk Factors; Tumor Necrosis Factor-alpha; Uric Acid | 2015 |
Elevated total plasma homocysteine levels are associated with type 2 diabetes in women with hypertension.
Topics: Adult; Aged; China; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Hypertension; Male; Middle Aged; Odds Ratio; Risk Factors; Sex Factors | 2015 |
Folic Acid and Vitamins D and B12 Correlate With Homocysteine in Chinese Patients With Type-2 Diabetes Mellitus, Hypertension, or Cardiovascular Disease.
Topics: Aged; Aged, 80 and over; Asian People; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dietary Supplements; Female; Folic Acid; Homocysteine; Humans; Hypertension; Male; Vitamin B 12; Vitamin D | 2016 |
Association between plasma homocysteine levels and end-organ damage in newly diagnosed type 2 diabetes mellitus patients.
Topics: Aged; Carotid Artery Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Cardiomyopathies; Diabetic Nephropathies; Female; Homocysteine; Humans; Male; Middle Aged | 2017 |
Elevated homocysteine levels in type 2 diabetes induce constitutive neutrophil extracellular traps.
Topics: Blood Platelets; Calcium; Cell-Free Nucleic Acids; Diabetes Mellitus, Type 2; Extracellular Traps; Female; Homocysteine; Humans; Leukocyte Elastase; Male; Middle Aged; NADPH Oxidases; Neutrophils; Up-Regulation | 2016 |
[Correlation of homocysteine with diabetic microangiopathy and the change after drug intervention].
Topics: Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Homocysteine; Humans; Lipids; Risk Factors | 2016 |
Menopause modulates homocysteine levels in diabetic and non-diabetic women.
Topics: Adult; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Menopause; Middle Aged | 2008 |
Homocysteine enhances LDL fatty acid peroxidation, promoting microalbuminuria in type 2 diabetes.
Topics: Aged; Albuminuria; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Fatty Acids; Female; Homocysteine; Humans; Lipoproteins, LDL; Male; Middle Aged; Oxidants; Peroxides; Risk Factors; Thiobarbituric Acid Reactive Substances | 2008 |
Plasma homocysteine thiolactone associated with risk of macrovasculopathy in Chinese patients with type 2 diabetes mellitus.
Topics: Age Factors; Asian People; Body Mass Index; China; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Folic Acid; Homocysteine; Humans; Lipids; Male; Middle Aged; Risk Factors; Smoking; Time Factors; Vitamin B 12 | 2008 |
Selenium levels in first-degree relatives of diabetic patients.
Topics: Adult; Blood Pressure; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Insulin; Lipids; Male; Middle Aged; Pedigree; Selenium | 2009 |
Oxidative damage indices for the assessment of subclinical diabetic macrovascular complications.
Topics: Aged; Antioxidants; Biomarkers; Blood Glucose; Cardiovascular Diseases; Cholesterol; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Fibrin Fibrinogen Degradation Products; Glutathione; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Oxidative Stress; Retrospective Studies | 2008 |
Effect of homocysteine on calcium mobilization and platelet function in type 2 diabetes mellitus.
Topics: Adenosine Diphosphate; Aged; Blood Platelets; Calcium; Calcium Signaling; Case-Control Studies; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Homocysteine; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation; Reactive Oxygen Species; Thapsigargin; Thrombin | 2008 |
Impaired endothelial function and insulin action in first-degree relatives of patients with type 2 diabetes mellitus.
Topics: Acetylcholine; Adenosine; Adult; Blood Gas Analysis; Blood Glucose; C-Peptide; C-Reactive Protein; Cholesterol; Diabetes Mellitus, Type 2; Endothelium, Vascular; Family; Glucose Clamp Technique; Homocysteine; Humans; Insulin; Insulin Resistance; Male; Plethysmography; Potassium; Statistics, Nonparametric; Vascular Resistance; Vasodilator Agents | 2009 |
[Changes of plasma total homocysteine in type I diabetic patients its association with diabetic vascular complications].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Homocysteine; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Young Adult | 2008 |
[Levels of homocysteine and polymorphisms of homocysteine metabolism-related enzymes in patients with type 2 diabetes mellitus and coronary heart disease].
Topics: Adult; China; Coronary Disease; Cystathionine beta-Synthase; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic | 2009 |
Methyltetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia as a novel risk factor for diabetic nephropathy.
Topics: Adult; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Disease Susceptibility; Female; Gene Frequency; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Point Mutation; Polymorphism, Single Nucleotide; Risk Factors | 2009 |
Increases in plasma holotranscobalamin can be used to assess vitamin B-12 absorption in individuals with low plasma vitamin B-12.
Topics: Adult; Body Height; Body Weight; Cardiovascular Diseases; Child; Diabetes Mellitus, Type 2; Fathers; Female; Folic Acid; Hemoglobins; Homocysteine; Humans; Intestinal Absorption; Male; Maternal Nutritional Physiological Phenomena; Mother-Child Relations; Transcobalamins; Vitamin B 12; Vitamin B 12 Deficiency | 2009 |
[Assessment of the level of homocysteine and the state of haemostasis in patients with and without type 2 diabetes mellitus in remote terms after reconstructive operations on the aorto-iliac segment].
Topics: Aged; Antithrombin III; Aorta, Abdominal; Blood Vessel Prosthesis Implantation; Data Interpretation, Statistical; Diabetes Mellitus, Type 2; Female; Fibrinogen; Follow-Up Studies; Hemostasis; Homocysteine; Humans; Iliac Artery; Leg; Male; Middle Aged; Plastic Surgery Procedures; Platelet Aggregation; Postoperative Complications; Thromboplastin; Time Factors | 2009 |
Serum N-terminal-pro-brain natriuretic peptide (NT-pro-BNP) and homocysteine levels in type 2 diabetic patients with asymptomatic left ventricular diastolic dysfunction.
Topics: Blood Pressure; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diastole; Echocardiography; Echocardiography, Transesophageal; Female; Homocysteine; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Ventricular Dysfunction, Left; Ventricular Function, Left | 2010 |
Plasma total homocysteine levels and methylenetetrahydrofolate reductase gene polymorphism in patients with type 2 diabetes mellitus.
Topics: Adult; Brazil; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide | 2008 |
[Side effects of caffeine].
Topics: Abortion, Spontaneous; Arteries; Caffeine; Cholesterol; Coronary Disease; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Type 2; DNA Copy Number Variations; Elasticity; Esophageal Sphincter, Lower; Female; Fetal Growth Retardation; Glucose; Homocysteine; Humans; Hypertension; Insulin Resistance; Pregnancy; Risk Factors | 2009 |
Plasminogen activator inhibitor-1 (PAI-1) activity and retinal vascular calibre in type 2 diabetes.
Topics: Adult; Aged; Aged, 80 and over; Arterioles; Blood Glucose; Blood Pressure; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Female; Glycated Hemoglobin; Heart Rate; Homocysteine; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Regression Analysis; Retinal Artery; Retinal Vein; Retinal Vessels; Risk Factors; Venules; Waist-Hip Ratio | 2010 |
Plasma homocysteine levels are associated with ulceration of the foot in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Albuminuria; Apolipoproteins B; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Foot; Female; Glycated Hemoglobin; Homocysteine; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Risk | 2010 |
Comment on: Song et al. (2009) Effect of homocysteine-lowering treatment with folic acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial. Diabetes 58:1921-1928.
Topics: Diabetes Mellitus, Type 2; Female; Folic Acid; Homocysteine; Humans; Randomized Controlled Trials as Topic; Risk Factors; Vitamin B Complex | 2010 |
Homocysteine induces caspase activation by endoplasmic reticulum stress in platelets from type 2 diabetics and healthy donors.
Topics: Apoptosis; Blood Donors; Blood Platelets; Calcium Signaling; Caspase 3; Caspase 9; Cells, Cultured; Cinnamates; Diabetes Mellitus, Type 2; Diabetic Angiopathies; eIF-2 Kinase; Endoplasmic Reticulum; Enzyme Activation; Homocysteine; Humans; Hyperhomocysteinemia; Stress, Physiological; Thiourea | 2010 |
Age and homocystein were risk factor for peripheral arterial disease in elderly with type 2 diabetes mellitus.
Topics: Age Factors; Aged; Aged, 80 and over; Case-Control Studies; Diabetes Mellitus, Type 2; Homocysteine; Humans; Incidence; Indonesia; Peripheral Arterial Disease; Risk Factors | 2010 |
Differential contribution of MTHFR C677T variant to the risk of diabetic nephropathy in Lebanese and Bahraini Arabs.
Topics: Adult; Alleles; Amino Acid Substitution; Arabs; Bahrain; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Lebanon; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Odds Ratio; Polymorphism, Single Nucleotide | 2010 |
Effect of lipopenic and hypotensive treatment on homocysteine levels in type 2 diabetics.
Topics: Aged; Antihypertensive Agents; Biomarkers; Case-Control Studies; Chi-Square Distribution; Diabetes Mellitus, Type 2; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Hypolipidemic Agents; Male; Middle Aged; Odds Ratio; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Triglycerides; Vitamin B 12 | 2010 |
Age, homocysteine, and oxidative stress: relation to hypertension and type 2 diabetes mellitus.
Topics: Adult; Age Factors; Aged; Aging; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Hypertension; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Reactive Oxygen Species | 2010 |
Association between plasma homocysteine and microalbuminuria in persons without hypertension, diabetes mellitus, and cardiovascular disease.
Topics: Adult; Albuminuria; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Hypertension; Male | 2011 |
Homocysteine levels are associated with hippocampus volume in type 2 diabetic patients.
Topics: Aged; Brain Mapping; Diabetes Mellitus, Type 2; Female; Hippocampus; Homocysteine; Humans; Insulin Resistance; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests | 2011 |
Early reduction of circulating homocysteine levels in Goto-Kakizaki rat, a spontaneous nonobese model of type 2 diabetes.
Topics: Age Factors; Animals; Body Weight; Diabetes Mellitus, Type 2; Disease Models, Animal; Glutathione; Homocysteine; Insulin Resistance; Male; Rats; Rats, Wistar | 2011 |
Association of homocysteine with peripheral neuropathy in Chinese patients with type 2 diabetes.
Topics: Aged; Asian People; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Homocysteine; Humans; Male; Middle Aged; Peripheral Nervous System Diseases | 2011 |
Macrophage cholesterol efflux to plasma and HDL in subjects with low and high homocysteine levels: a FIELD substudy.
Topics: Aged; Aryldialkylphosphatase; Cells, Cultured; Cholesterol; Cholesterol, HDL; Cohort Studies; Diabetes Mellitus, Type 2; Female; Fenofibrate; Foam Cells; High-Density Lipoproteins, Pre-beta; Homocysteine; Humans; Macrophages; Male; Middle Aged; Particle Size; Phospholipid Transfer Proteins | 2011 |
Endothelial function after 10 days of bed rest in individuals at risk for type 2 diabetes and cardiovascular disease.
Topics: Acetylcholine; Adenosine; Adult; Bed Rest; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Endothelium, Vascular; Forearm; Homocysteine; Humans; Hyperinsulinism; Infant, Low Birth Weight; Infant, Newborn; Insulin; Intercellular Adhesion Molecule-1; Male; Regional Blood Flow; Risk; Vascular Cell Adhesion Molecule-1; Vasodilation | 2011 |
Influence of duration of diabetes mellitus, glycemic control, and traditional cardiovascular risk factors on abdominal aortic diameter in older adults with type 2 diabetes mellitus.
Topics: Age Factors; Aged; Aorta, Abdominal; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Homocysteine; Humans; Hypertension; Male; Risk Factors; Sex Factors; Time Factors; Ultrasonography | 2011 |
Tissue-specific alterations of methyl group metabolism with DNA hypermethylation in the Zucker (type 2) diabetic fatty rat.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Animals; Cystathionine beta-Synthase; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Glycine N-Methyltransferase; Homocysteine; Kidney; Liver; Male; Organ Specificity; Rats; Rats, Zucker | 2012 |
Role of ischemia-modified albumin and total homocysteine in estimating symptomatic lacunar infarction in type 2 diabetic patients.
Topics: Adult; Aged; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Linear Models; Male; Middle Aged; Myocardial Ischemia; ROC Curve; Serum Albumin; Serum Albumin, Human; Stroke, Lacunar | 2011 |
Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus.
Topics: Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Foot; Diabetic Neuropathies; Female; Homocysteine; Humans; Lipoprotein(a); Logistic Models; Male; Middle Aged; Peripheral Arterial Disease; Risk Factors; Wound Healing | 2012 |
Characteristics of bone turnover, bone mass and bone strength in Spontaneously Diabetic Torii-Lepr fa rats.
Topics: Amino Acids; Animals; Blood Glucose; Body Weight; Bone Density; Bone Remodeling; Calcium; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Femur; Homocysteine; Imaging, Three-Dimensional; Male; Organ Size; Osteocalcin; Radiography; Rats; Receptors, Leptin; Tibia | 2012 |
[Relationship between plasma total homocysteine and mild cognitive impairment in senile patients with type 2 diabetes].
Topics: Aged; Cognition Disorders; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Homocysteine; Humans; Insulin; Insulin Resistance; Male | 2011 |
Plasma retinol: a novel marker for cardiovascular disease mortality in Australian adults.
Topics: Aged; Australia; Biomarkers; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Carotenoids; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Incidence; Life Style; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Prospective Studies; Regression Analysis; Risk Factors; Surveys and Questionnaires; Vitamin A | 2012 |
Evaluation of oxidative stress markers and vascular risk factors in patients with diabetic peripheral neuropathy.
Topics: Adult; Aged; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Erythrocytes; Female; gamma-Glutamyltransferase; Glutathione; Glycated Hemoglobin; Homocysteine; Humans; Male; Middle Aged; Oxidative Stress; Prevalence; Prognosis; Risk Factors | 2012 |
Relation of homocysteine to early nephropathy in patients with Type 2 diabetes.
Topics: Adult; Aged; Albuminuria; Algorithms; Biomarkers; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diagnosis, Differential; Early Diagnosis; Female; Homocysteine; Humans; Inpatients; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Sensitivity and Specificity; Surveys and Questionnaires | 2012 |
Variability of plasma and urine betaine in diabetes mellitus and its relationship to methionine load test responses: an observational study.
Topics: Aged; Betaine; Biomarkers; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Glycosuria; Homocysteine; Humans; Linear Models; Male; Methionine; Middle Aged; New Zealand; Predictive Value of Tests; Reproducibility of Results; Sarcosine; Time Factors | 2012 |
[Correlation of homocysteine in plasma with NOS and endogenous CO in the penile corpus cavernosum of type 2 diabetic rats].
Topics: Animals; Carbon Monoxide; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Folic Acid; Homocysteine; Insulin; Male; Nitric Oxide Synthase; Penis; Rats; Rats, Wistar; Vitamin B 12 | 2012 |
[Hyperhomocysteinemia and plasma acute-phase proteins in patients with type 2 diabetes mellitus and severe course of atherosclerosis after vascular operations].
Topics: Atherosclerosis; C-Reactive Protein; Diabetes Mellitus, Type 2; Disease Progression; Female; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Male; Middle Aged; Postoperative Complications; Risk Assessment; Severity of Illness Index; Statistics as Topic; Vascular Surgical Procedures | 2011 |
Plasma phospholipid polyunsaturated fatty acids and homocysteine in Chinese type 2 diabetes patients.
Topics: Adult; Aged; Algorithms; China; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Outpatient Clinics, Hospital; Phospholipids; Prevalence; Vitamin B 12 | 2012 |
Plasma homocysteine levels are independently associated with the severity of peripheral polyneuropathy in type 2 diabetic subjects.
Topics: Aged; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Homocysteine; Humans; Male; Middle Aged | 2012 |
Relationship between homocysteine and non-dipper pattern in patients with type 2 diabetes mellitus.
Topics: Blood Glucose; Blood Pressure; Cardiovascular Diseases; Case-Control Studies; Circadian Rhythm; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged | 2012 |
Elevated plasma homocysteine in type 2 diabetes mellitus: a risk factor for cardiovascular diseases.
Topics: Aged; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors | 2012 |
Evaluation of plasma homocysteine level according to the C677T and A1298C polymorphism of the enzyme MTHRF in type 2 diabetic adults.
Topics: Adult; Case-Control Studies; Diabetes Mellitus, Type 2; Fasting; Female; Genotype; Homocysteine; Humans; Male; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic | 2012 |
Validation and clinical application of an UHPLC method for simultaneous analysis of total homocysteine and cysteine in human plasma.
Topics: Chromatography, High Pressure Liquid; Cysteine; Diabetes Mellitus, Type 2; Homocysteine; Humans; Hydrogen-Ion Concentration; Limit of Detection; Reproducibility of Results | 2012 |
[Correlation between plasma concentrations of homocysteine and diabetic polyneuropathy evaluated with the Semmes-Weinstein monofilament test in patients with type 2 diabetes mellitus].
Topics: Age Factors; Aged; Alcohol Drinking; Cardiovascular Diseases; Case-Control Studies; Creatinine; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Disease Progression; Female; Folic Acid; Glycated Hemoglobin; Homocysteine; Humans; Hyperhomocysteinemia; Hypesthesia; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Overweight; Physical Examination; Risk Factors; Severity of Illness Index; Smoking; Vitamin B 12 | 2013 |
[The abnormal reaction to post methionine loading test in type diabetes with or without retinopathy].
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Fasting; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Nitrates; Oxidoreductases Acting on CH-NH Group Donors; Time Factors | 2002 |
Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus.
Topics: Apolipoproteins; Biomarkers; Blood Glucose; Blood Pressure; C-Reactive Protein; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glycated Hemoglobin; Homocysteine; Humans; Interleukin-6; Lipoproteins; Male; Middle Aged; Multivariate Analysis; N-Acetylneuraminic Acid; Regression Analysis; Risk Factors | 2002 |
Association between homocysteinemia and renal function in patients with type 2 diabetes mellitus.
Topics: Adult; Albuminuria; Creatinine; Cystatin C; Cystatins; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Kidney; Male; Middle Aged; Osmolar Concentration | 2002 |
Is diabetic hypercoagulability an acquired annexinopathy? Glycation of annexin II as a putative mechanism for impaired fibrinolysis in diabetic patients.
Topics: Animals; Annexin A2; Clinical Trials, Phase III as Topic; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Fibrinolysis; Glycation End Products, Advanced; Glycosylation; Homocysteine; Hyperhomocysteinemia; Lipoprotein(a); Plasminogen; Risk Factors; Thrombophilia; Tissue Plasminogen Activator | 2002 |
Proteinuria as a predictor of total plasma homocysteine levels in type 2 diabetic nephropathy.
Topics: Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Proteinuria | 2002 |
Plasmatic homocysteine concentration and its relationship with complications associated to diabetes mellitus.
Topics: Adult; Aged; Analysis of Variance; Biomarkers; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Regression Analysis | 2002 |
Associations of plasma homocysteine concentration in subjects with type 2 diabetes mellitus.
Topics: Albuminuria; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retinopathy; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Osmolar Concentration | 2002 |
The relationship between MTHFR gene polymorphisms, plasma homocysteine levels and diabetic retinopathy in type 2 diabetes mellitus.
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic | 2003 |
[The relationship of methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in type 2 diabetes mellitus patients with diabetic retinopathy].
Topics: Adult; Alleles; Deoxyribonucleases, Type II Site-Specific; Diabetes Mellitus, Type 2; Diabetic Retinopathy; DNA; Female; Gene Frequency; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Polymorphism, Genetic | 2003 |
Relation between total homocysteine levels and beer intake in patients with diabetes mellitus Type 2.
Topics: Aged; Beer; Diabetes Mellitus, Type 2; Dietary Proteins; Female; Homocysteine; Humans; Male; Middle Aged; Nutrition Assessment; Regression Analysis | 2003 |
Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes.
Topics: Age Factors; Analysis of Variance; Arizona; Biomarkers; Blood Glucose; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Folic Acid; Homocysteine; Humans; Incidence; Indians, North American; Longitudinal Studies; Male; Middle Aged; Vitamin B 12 | 2003 |
Effect of smoking on risk factors for cardiovascular disease in patients with diabetes mellitus and renal insufficiency.
Topics: Adult; Aged; Arginine; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycation End Products, Advanced; Homocysteine; Humans; Kidney Transplantation; Lysine; Middle Aged; Renal Dialysis; Renal Insufficiency; Risk Factors; Smoking | 2003 |
Effect of metabolic control on homocysteine levels in type 2 diabetic patients: a 3-year follow-up.
Topics: Aged; Analysis of Variance; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glycated Hemoglobin; Homocysteine; Humans; Male; Mutation; Prospective Studies | 2003 |
Relationships of plasma interleukin-18 concentrations to hyperhomocysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes.
Topics: Biomarkers; C-Reactive Protein; Carotid Arteries; Carotid Stenosis; Cholesterol; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Homocysteine; Humans; Hyperhomocysteinemia; Interleukin-18; Middle Aged; Reference Values; Tunica Intima; Tunica Media | 2003 |
Thiols, malonaldehyde and total antioxidant status in the Turkish patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Antioxidants; Blood Glucose; Case-Control Studies; Catalysis; Chromatography, High Pressure Liquid; Cysteine; Diabetes Mellitus, Type 2; Dipeptides; Female; gamma-Glutamyltransferase; Glutathione; Homocysteine; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Sex Factors; Smoking; Sulfhydryl Compounds; Turkey | 2003 |
Homocysteine levels are associated with the severity of peripheral arterial disease in Type 2 diabetic patients.
Topics: Aged; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Folic Acid; Homocysteine; Humans; Italy; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Peripheral Vascular Diseases; ROC Curve; Vitamin B 6 | 2003 |
Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
Topics: Adult; Aged; Atorvastatin; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Heptanoic Acids; Homocysteine; Humans; Hypercholesterolemia; Kidney Failure, Chronic; Lipid Metabolism; Lipids; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Prospective Studies; Pyrroles; Renal Dialysis; Risk Factors | 2003 |
Evidence suggests diabetes outcomes linked to homocysteine.
Topics: Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Vitamin B Complex | 2003 |
Plasma homocysteine after insulin infusion in type II diabetic patients with and without methionine intolerance.
Topics: Blood Glucose; Cysteine; Diabetes Mellitus, Type 2; DNA; Female; Folic Acid; Glucose Clamp Technique; Homocysteine; Humans; Hyperhomocysteinemia; Insulin; Male; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Point Mutation; Polymerase Chain Reaction; Vitamin B 12; Vitamin B 6 | 2004 |
High blood sugar, homocysteine boost artery-reclogging risks.
Topics: Blood Glucose; Coronary Restenosis; Diabetes Mellitus, Type 2; Homocysteine; Humans; Risk Factors | 2004 |
Correlates of total homocysteine plasma concentration in type 2 diabetes.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Fasting; Female; Genotype; Homocysteine; Humans; Life Style; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Nutritional Physiological Phenomena; Polymorphism, Genetic; Sex Factors | 2004 |
[Homocysteine and C-reactive protein concentrations in serum of diabetic patients].
Topics: Aged; Blood Glucose; Body Mass Index; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Lipids; Male; Middle Aged; Sex Factors; Triglycerides | 2003 |
Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients.
Topics: Asian People; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Risk Factors; Spectrometry, Fluorescence | 2004 |
Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia.
Topics: Albuminuria; alpha-2-Antiplasmin; Biomarkers; Blood Coagulation; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Interleukin-6; Linear Models; Male; Middle Aged; Protein C | 2004 |
Coffee: for most, it's safe. Coffee has been blamed for everything from moral turpitude to cancer. But none of the bad raps have stuck. Coffee may even be good for you.
Topics: Caffeine; Cardiovascular System; Coffee; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Liver Diseases; Neoplasms; Osteoporosis; Parkinson Disease; Pregnancy | 2004 |
Effect of metformin on plasma homocysteine, vitamin B12 and folic acid: a cross-sectional study in patients with type 2 diabetes mellitus.
Topics: Adult; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Folic Acid; Homocysteine; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Vitamin B 12 | 2004 |
C677T methylene-tetrahydrofolate reductase mutation in type 2 diabetic patients with and without hyperhomocysteinaemia.
Topics: Aged; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypoglycemic Agents; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Point Mutation; Reference Values | 2004 |
Study of total homocyst(e)ine levels in type 2 diabetic patients with silent brain infarction.
Topics: Cerebral Infarction; Cerebral Ventricles; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Female; Homocysteine; Humans; Lipid Peroxidation; Male; Middle Aged; Prospective Studies; Reactive Oxygen Species | 2003 |
Plasma homocysteine and insulin in diabetic nephropathy: relationship to body mass index.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Body Mass Index; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Homocysteine; Humans; Insulin; Male; Middle Aged; Prospective Studies; Reference Values; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index | 2004 |
Methylenetetrahydrofolate reductase polymorphism associated with susceptibility to coronary heart disease in Chinese type 2 diabetic patients.
Topics: Asian People; Case-Control Studies; Coronary Disease; Diabetes Mellitus, Type 2; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Predictive Value of Tests; Risk Factors | 2005 |
[Relation between diabetes compensation, albuminuria and biochemical parameters and the results of stress myocardial SPECT in asymptomatic type 2 diabetics].
Topics: Albuminuria; C-Reactive Protein; Coronary Circulation; Coronary Disease; Diabetes Mellitus, Type 2; Exercise Test; Female; Fibrinogen; Homocysteine; Humans; Male; Middle Aged; Tomography, Emission-Computed, Single-Photon; Uric Acid | 2004 |
[Relationship between plasma homocysteine and chronic complications in type 2 diabetes mellitus].
Topics: Adult; Aged; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged | 2005 |
Disturbed homocysteine and methionine cycle intermediates S-adenosylhomocysteine and S-adenosylmethionine are related to degree of renal insufficiency in type 2 diabetes.
Topics: Aged; Cystathionine; Cysteine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Folic Acid; Homocysteine; Humans; Kidney; Kidney Failure, Chronic; Male; Methionine; Methylmalonic Acid; Middle Aged; S-Adenosylhomocysteine; S-Adenosylmethionine; Transcobalamins; Vitamin B 12; Vitamin B 6 | 2005 |
Vascular risk and low serum B12 predict white matter lesions in patients with major depression.
Topics: Adult; Aged; Aged, 80 and over; Brain; Cerebral Cortex; Cerebral Ventricles; Cohort Studies; Comorbidity; Depressive Disorder, Major; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Hypertension; Hypertensive Encephalopathy; Intracranial Arteriosclerosis; Magnetic Resonance Imaging; Male; Middle Aged; Reference Values; Risk Factors; Statistics as Topic; Vitamin B 12 Deficiency | 2005 |
Prevalence of myocardial infarction is related to hyperhomocysteinemia but not influenced by C677T methylenetetrahydrofolate reductase and A2756G methionine synthase polymorphisms in diabetic and non-diabetic subjects.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adult; Aged; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Polymorphism, Single Nucleotide; Regression Analysis | 2005 |
Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria.
Topics: Adult; Aged; Albuminuria; Antioxidants; Diabetes Mellitus, Type 2; Female; Glutathione; Glutathione Peroxidase; Homocysteine; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Vascular Diseases | 2005 |
Thermolabile methylenetetrahydrofolate reductase enzyme genotype is frequent in type 2 diabetic patients with normal fasting homocysteine levels.
Topics: Adult; Case-Control Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Electrophoresis, Polyacrylamide Gel; Female; Genetic Predisposition to Disease; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic | 2005 |
Adiponectin levels and cardiovascular risk factors in Japanese men with type 2 diabetes.
Topics: Adiponectin; Adult; Aging; Body Mass Index; Cardiovascular Diseases; Cholesterol, HDL; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Folic Acid; gamma-Glutamyltransferase; Glycated Hemoglobin; Homocysteine; Humans; Intercellular Signaling Peptides and Proteins; Japan; Leukocyte Count; Lipids; Male; Middle Aged; Risk Factors; Smoking | 2005 |
Plasma homocysteine levels in patients with type 2 diabetes in a Mediterranean population: relation with nutritional and other factors.
Topics: Adult; Aged; Alcohol Drinking; Animals; Blood Glucose; Blood Pressure; Coffee; Diabetes Mellitus, Type 2; Diet; Exercise; Female; Fishes; Folic Acid; Fruit; Glomerular Filtration Rate; Glycated Hemoglobin; Homocysteine; Humans; Linear Models; Male; Meat; Mediterranean Region; Metformin; Middle Aged; Nutritional Status; Surveys and Questionnaires; Triglycerides; Vegetables | 2005 |
Reduced serum homocysteine levels in type 2 diabetes.
Topics: Adult; Blood Pressure; Body Mass Index; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diet; Female; Genotype; Homocysteine; Humans; Hypoglycemic Agents; Insulin; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Polymorphism, Restriction Fragment Length; Sex Characteristics; Triglycerides; Uric Acid | 2005 |
Association of plasma homocysteine with serum interleukin-6 and C-peptide levels in patients with type 2 diabetes.
Topics: Aged; C-Peptide; Diabetes Mellitus, Type 2; Female; Genotype; Homocysteine; Humans; Interleukin-6; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis | 2005 |
Homocysteine, vitamin B 12 and folate in Alzheimer's and vascular dementias: the paradoxical effect of the superimposed type II diabetes mellitus condition.
Topics: Aged; Alzheimer Disease; Analysis of Variance; Dementia, Vascular; Diabetes Mellitus, Type 2; Female; Folic Acid; Homocysteine; Humans; Male; Vitamin B 12 | 2005 |
Inverse association between plasma homocysteine, sulphonylurea exposure and physical activity: a community-based sample of type 2 diabetes patients in the Skaraborg hypertension and diabetes project.
Topics: Aged; Blood Glucose; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Exercise; Female; Glycated Hemoglobin; Homocysteine; Humans; Hypoglycemic Agents; Kidney; Life Style; Male; Metabolic Syndrome; Risk Factors; Sex Factors; Sulfonylurea Compounds | 2005 |
Homocysteine concentrations and vascular complications in patients with type 2 diabetes.
Topics: Age of Onset; Aged; Biomarkers; Blood Pressure; Body Mass Index; Body Size; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Homocysteine; Humans; Hyperhomocysteinemia; Middle Aged; Reference Values; Risk Factors | 2005 |
Plasma total homocysteine concentrations in obese and non-obese female patients with type 2 diabetes mellitus; its relations with plasma oxidative stress and nitric oxide levels.
Topics: Blood Pressure; Case-Control Studies; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Homocysteine; Humans; Insulin; Lipid Peroxidation; Middle Aged; Nitric Oxide; Obesity; Oxidative Stress; Thiobarbituric Acid Reactive Substances | 2005 |
[Arterial wave velocity and coronary risk factors in patients with type-2 diabetes].
Topics: Aged; Aged, 80 and over; Albuminuria; Blood Flow Velocity; Cardiovascular Diseases; Compliance; Coronary Vessels; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors | 2005 |
Effect of rosiglitazone on homocysteine and creatinine levels in patients with type 2 diabetes.
Topics: Biomarkers; Creatinine; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Homocysteine; Humans; Hypoglycemic Agents; Kidney; Male; Middle Aged; Rosiglitazone; Thiazolidinediones | 2005 |
Heavy alcohol intake, homocysteine and Type 2 diabetes.
Topics: Alcohol Drinking; Arteriosclerosis; Blood Glucose; Creatinine; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Folic Acid; gamma-Glutamyltransferase; Homocysteine; Humans; Male; Middle Aged; Prevalence; Risk Factors; Vitamin B 12 | 2005 |
Effects of insulin on methionine and homocysteine kinetics in type 2 diabetes with nephropathy.
Topics: Blood Glucose; Carbon Dioxide; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fasting; Food; Glucose Clamp Technique; Glycated Hemoglobin; Heterozygote; Homocysteine; Homozygote; Humans; Insulin; Kinetics; Male; Methionine; Methylation; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Sulfur | 2005 |
Homocysteine, type 2 diabetes mellitus, and cognitive performance: The Maine-Syracuse Study.
Topics: Cognition; Cognition Disorders; Diabetes Mellitus, Type 2; Homocysteine; Humans; Maine; Middle Aged; New York | 2005 |
Plasma homocysteine levels in noninsulin-dependent diabetes mellitus with retinopathy and neovascular glaucoma.
Topics: Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glaucoma, Neovascular; Homocysteine; Humans; Middle Aged; Risk Factors | 2004 |
Homocysteine metabolism in ZDF (type 2) diabetic rats.
Topics: Animals; Betaine; Cells, Cultured; Diabetes Mellitus, Type 2; Gene Expression Regulation, Enzymologic; Hepatocytes; Homocysteine; Insulin Resistance; Liver; Methionine; Phosphatidylcholines; Rats; Rats, Zucker; RNA, Messenger | 2005 |
Homocysteine levels are not associated with cardiovascular autonomic function in elderly Caucasian subjects without or with type 2 diabetes mellitus: the Hoorn Study.
Topics: Age Factors; Aged; Antihypertensive Agents; Autonomic Nervous System; Blood Pressure; Creatinine; Diabetes Mellitus, Type 2; Female; Glucose; Glucose Metabolism Disorders; Glucose Tolerance Test; Heart Rate; Homocysteine; Humans; Hyperhomocysteinemia; Insulin; Male; Middle Aged; Sex Factors; Waist-Hip Ratio | 2005 |
Homocysteine and other biochemical parameters in Type 2 diabetes mellitus with different diabetic duration or diabetic retinopathy.
Topics: Aged; Albuminuria; Bilirubin; Biomarkers; Blood Glucose; C-Reactive Protein; Chromatography, High Pressure Liquid; Creatine Kinase; Creatinine; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glycated Hemoglobin; Homocysteine; Humans; L-Lactate Dehydrogenase; Lipids; Male; Middle Aged; Time Factors; Uric Acid | 2006 |
[Homocysteinaemia and degenerative complications in non insulin dependent diabetes mellitus].
Topics: Cardiovascular Diseases; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Homocysteine; Humans; Male | 2005 |
Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.
Topics: Aged; Arginine; Arterial Occlusive Diseases; Biomarkers; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Homocysteine; Humans; Hypoglycemic Agents; Incidence; Male; Middle Aged; Nitric Oxide Synthase; Prognosis; Risk Factors; Severity of Illness Index | 2006 |
[Study on the associations between inflammatory factor and insulin resistance as well as type 2 diabetes with macrovascular complications].
Topics: C-Reactive Protein; Case-Control Studies; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Homeostasis; Homocysteine; Humans; Inflammation Mediators; Insulin Resistance; Linear Models; Male; Middle Aged | 2005 |
Soluble tumor necrosis factor receptor 1 is strongly and independently associated with serum homocysteine in nonobese Japanese type 2 diabetic patients.
Topics: Body Mass Index; Creatinine; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Homocysteine; Humans; Japan; Receptors, Tumor Necrosis Factor, Type I; Regression Analysis | 2006 |
Pioglitazone mitigates renal glomerular vascular changes in high-fat, high-calorie-induced type 2 diabetes mellitus.
Topics: Animals; Arterioles; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dietary Fats; Hemodynamics; Homocysteine; Kidney Glomerulus; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Nitric Oxide; Oxidative Stress; Phenylephrine; Pioglitazone; Thiazolidinediones | 2006 |
The FIELD study.
Topics: Diabetes Mellitus, Type 2; Fenofibrate; Homocysteine; Humans; Hypolipidemic Agents; Risk Factors; Venous Thrombosis | 2006 |
Patterns of homocysteine in Kenyans with type 2 diabetes without overt cardiovascular disease at Kenyatta National Hospital, Nairobi.
Topics: Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Homocysteine; Humans; Kenya; Male; Middle Aged; Outpatient Clinics, Hospital; Prospective Studies; Risk Assessment; Risk Factors; Time Factors | 2005 |
[The relationship between metabolic control and the plasma total homocysteine in type 2 diabetes treated with insulin].
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Homocysteine; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged | 2006 |
Mild hyperhomocysteinemia and the common C677T polymorphism of methylene tetrahydrofolate reductase gene are not associated with the metabolic syndrome in Type 2 diabetes.
Topics: Adult; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Female; Folic Acid; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Insulin Resistance; Linear Models; Male; Metabolic Syndrome; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Obesity; Polymorphism, Genetic; Triglycerides; Vitamin B 12 | 2006 |
A prospective cohort study of predictive value of homocysteine in patients with type 2 diabetes and coronary artery disease.
Topics: Aged; Cohort Studies; Comorbidity; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Germany; Homocysteine; Humans; Linear Models; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Risk Factors; Sensitivity and Specificity; Survival Rate | 2006 |
MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Risk Factors; Tunisia | 2007 |
Homocysteine and vitamin B(12) concentrations and mortality rates in type 2 diabetes.
Topics: Adult; Aged; Aged, 80 and over; Arizona; Cardiovascular Diseases; Cause of Death; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Folic Acid; Homocysteine; Humans; Indians, North American; Infections; Longitudinal Studies; Male; Middle Aged; Proportional Hazards Models; Serum Albumin; Vitamin B 12 | 2007 |
G1793A polymorphisms in the methylene-tetrahydrofolate gene: effect of folic acid on homocysteine levels.
Topics: Adult; Aged; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Dietary Supplements; Female; Folic Acid; Gene Frequency; Heterozygote; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Vitamin B 12 | 2006 |
Plasma homocysteine concentrations in young individuals at increased risk of type 2 diabetes are associated with subtle differences in glomerular filtration rate but not with insulin resistance.
Topics: Adult; Age Factors; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Homocysteine; Humans; Insulin; Insulin Resistance; Kidney Function Tests; Male; Middle Aged; Risk Factors; Risk Reduction Behavior; Statistics as Topic | 2006 |
Homocysteine levels are associated with the results of 123I-metaiodobenzylguanidine myocardial scintigraphy in type 2 diabetic patients.
Topics: 3-Iodobenzylguanidine; Biomarkers; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2007 |
[Factors influencing homocysteineamia in type 2 diabetic patients].
Topics: Diabetes Mellitus, Type 2; Female; Folic Acid; Glycated Hemoglobin; Homocysteine; Humans; Hyperhomocysteinemia; Hypoglycemic Agents; Male; Metformin; Middle Aged; Obesity; Prospective Studies; Risk Factors; Vitamin B 12; Vitamin B 12 Deficiency | 2006 |
Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy.
Topics: Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dietary Supplements; Disease Progression; Female; Genotype; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Phenotype; Polymorphism, Single Nucleotide; Time Factors | 2007 |
Circulating homocysteine levels in patients with type 2 diabetes mellitus.
Topics: Aged; Blood Glucose; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Folic Acid; Genotype; Glomerular Filtration Rate; Glycated Hemoglobin; Homocysteine; Humans; Linear Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Polymorphism, Genetic; Up-Regulation; Vitamin B 12 | 2008 |
[Increase of homocysteine in cardiovascular diseases in Hungary].
Topics: Adult; Aged; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; COUP Transcription Factor II; Diabetes Mellitus, Type 2; Factor XIII; Female; Folic Acid; Homocysteine; Humans; Hungary; Hyperhomocysteinemia; Linear Models; Male; Middle Aged; Patient Selection; Polymorphism, Genetic; Retrospective Studies; Risk Factors; Vitamin B 12 | 2006 |
Methylenetetrahydrofolate reductase gene polymorphism, homocysteine and risk of macroangiopathy in Type 2 diabetes mellitus.
Topics: Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Regression Analysis | 2006 |
Differences in expression of cardiovascular risk factors among type 2 diabetes mellitus patients of different age.
Topics: Adolescent; Adult; Aging; Biomarkers; C-Reactive Protein; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Homocysteine; Humans; Male; Reference Values; Risk Factors; Triglycerides | 2006 |
Association of cardiovascular risk factors and disease with depression in later life.
Topics: Age of Onset; Aged; Aged, 80 and over; Angina Pectoris; Cardiovascular Diseases; Cross-Sectional Studies; Depressive Disorder, Major; Diabetes Mellitus, Type 2; Homocysteine; Humans; Male; Myocardial Infarction; Risk Factors; Stroke; Surveys and Questionnaires; Triglycerides | 2007 |
Homocysteine, reactive oxygen species and nitric oxide in type 2 diabetes mellitus.
Topics: Aged; Case-Control Studies; Cyclic GMP; Diabetes Mellitus, Type 2; Glutathione; Homocysteine; Humans; Male; Middle Aged; Nitric Oxide; Platelet Activation; Reactive Oxygen Species | 2007 |
[Association of paraoxonase polymorphisms and serum homocysteine thiolactone complex with coronary heart disease].
Topics: Adult; Aged; Aryldialkylphosphatase; Coronary Disease; Cysteine; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Male; Middle Aged; Polymorphism, Genetic | 2006 |
Coffee and diabetes: is homocysteine the missing link?
Topics: Coffee; Diabetes Mellitus, Type 2; Homocysteine; Humans; Hyperhomocysteinemia; Multivariate Analysis; Regression Analysis | 2007 |
Hyperhomocysteinemia is associated with visceral adiposity in Japanese patients with type 2 diabetes mellitus.
Topics: Adipose Tissue; Aged; Diabetes Mellitus, Type 2; Echocardiography; Electrocardiography; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypoglycemic Agents; Japan; Male; Middle Aged; Viscera | 2007 |
Type 2 diabetes mellitus and colorectal cancer risk: is homocysteine the missing link?
Topics: Biomarkers; Colorectal Neoplasms; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Risk Factors | 2007 |
[Asymmetric dimethyl arginine (ADMA): a novel cardiovascular risk factor?].
Topics: Arginine; Coronary Artery Disease; Diabetes Mellitus, Type 2; Endothelium, Vascular; Homocysteine; Humans; Insulin Resistance; Myocardial Reperfusion Injury; Nitric Oxide; Nitric Oxide Synthase; Statistics as Topic | 2007 |
Association of serum resistin with TNF system activity in Japanese type 2 diabetic patients.
Topics: Albuminuria; Atherosclerosis; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Homocysteine; Humans; Japan; Resistin; Tumor Necrosis Factor-alpha | 2007 |
Beer ethanol consumption and plasma homocysteine among patients with type 2 diabetes.
Topics: Alcohol Drinking; Beer; Diabetes Mellitus, Type 2; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Regression Analysis; Vitamin B 12 | 2007 |
The influence of homocysteine levels on endothelial function and their relation with microvascular complications in T2DM patients without macrovascular disease.
Topics: Adult; Blood Flow Velocity; Brachial Artery; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Homocysteine; Humans; Male; Microcirculation; Middle Aged; Reference Values; Ultrasonography; Vasodilation | 2007 |
[Hyperhomocysteinemia in coronary artery disease and hemostasis disorders in patients with type 2 diabetes mellitus].
Topics: Blood Coagulation; Blood Platelets; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Tomography, Spiral Computed | 2007 |
Serum gamma-glutamyl transferase is associated with plasma total homocysteine in Japanese patients with type 2 diabetes.
Topics: Adult; Aged; Biomarkers; Diabetes Mellitus, Type 2; Female; gamma-Glutamyltransferase; Homocysteine; Humans; Japan; Life Style; Liver Function Tests; Male; Middle Aged; Oxidative Stress | 2007 |
Correlations between homocysteine levels and atherosclerosis in Japanese type 2 diabetic patients.
Topics: Aged; Anthropometry; Atherosclerosis; Blood Flow Velocity; Blood Glucose; Body Composition; Body Mass Index; Diabetes Mellitus, Type 2; Female; Homeostasis; Homocysteine; Humans; Insulin Resistance; Japan; Male; Middle Aged | 2007 |
Homocysteine, S-adenosylmethionine and S-adenosylhomocysteine are associated with retinal microvascular abnormalities: the Hoorn Study.
Topics: Aged; Aged, 80 and over; Arterioles; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Folic Acid; Follow-Up Studies; Glucose Tolerance Test; Homocysteine; Humans; Male; Middle Aged; Retinal Diseases; Retinal Vessels; S-Adenosylhomocysteine; S-Adenosylmethionine | 2008 |
Association of diabetes, homocysteine, and HDL with cognition and disability after stroke.
Topics: Aged; Brief Psychiatric Rating Scale; Cholesterol, HDL; Cognition; Cognition Disorders; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Longitudinal Studies; Male; Middle Aged; Randomized Controlled Trials as Topic; Risk Factors; Stroke | 2007 |
Effect of homocysteine on calcium mobilization and platelet function in type 2 diabetes mellitus.
Topics: Blood Platelets; Calcium; Case-Control Studies; Cell Shape; Diabetes Mellitus, Type 2; Female; Health; Homocysteine; Humans; Hydroquinones; Male; Middle Aged; Platelet Aggregation; Platelet Function Tests; Reactive Oxygen Species; Thrombin | 2008 |
Relation of plasma homocysteine levels to atherosclerotic vascular disease and inflammation markers in type 2 diabetic patients.
Topics: Aged; Atherosclerosis; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Fibrinogen; Homocysteine; Humans; Inflammation; Interleukin-6; Kidney Function Tests; Middle Aged; Tumor Necrosis Factor-alpha | 2008 |
Hyperhomocysteinaemia is a significant risk factor for white matter lesions in Japanese type 2 diabetic patients.
Topics: Blood Glucose; Brain Diseases; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Hyperhomocysteinemia; Insulin Resistance; Japan; Logistic Models; Male; Middle Aged; Neuroglia; Risk Factors | 2008 |
Plasma and vitreous homocysteine concentrations in patients with proliferative diabetic retinopathy.
Topics: Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Homocysteine; Humans; Laser Coagulation; Male; Middle Aged; Vitrectomy; Vitreous Body | 2008 |
Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatment.
Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Homocysteine; Humans; Injections, Intramuscular; Male; Middle Aged; Risk Factors; Vitamin B 12 | 1993 |
Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease.
Topics: Administration, Oral; Adult; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Homocysteine; Humans; Male; Methionine; Middle Aged; Time Factors | 1996 |
Oxidative stress in diabetic macrovascular disease: does homocysteine play a role?
Topics: Adult; Analysis of Variance; Brain Ischemia; Carotid Artery Diseases; Case-Control Studies; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Free Radicals; Homocysteine; Humans; Hypoglycemic Agents; Insulin; Lipid Peroxidation; Male; Methionine; Middle Aged; Oxidative Stress; Peripheral Vascular Diseases; Sulfonylurea Compounds; Thiobarbiturates | 1997 |
Does metformin increase the serum total homocysteine level in non-insulin-dependent diabetes mellitus?
Topics: Adult; Aged; Arteriosclerosis; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Risk Factors | 1997 |
Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study.
Topics: Aged; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Homocysteine; Humans; Male; Middle Aged; Population Surveillance; Risk; Sex Factors | 1998 |
Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects.
Topics: Acute Disease; Adult; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Homocysteine; Humans; Hyperinsulinism; Male; Middle Aged; Osmolar Concentration; Reference Values | 1998 |
Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study.
Topics: Aged; Albuminuria; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Dietary Proteins; Female; Glucose Tolerance Test; Homocysteine; Humans; Hypertension, Renal; Male; Middle Aged; Prevalence; Risk Factors | 1998 |
Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
Topics: Adult; Aged; Albuminuria; Analysis of Variance; Biomarkers; Body Mass Index; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Homocysteine; Humans; Hypertension; Lipids; Lipoproteins; Male; Middle Aged; Proteinuria; Regression Analysis; Vitamins | 1998 |
Fasting and post-methionine load homocyst(e)ine values are correlated with microalbuminuria and could contribute to worsening vascular damage in non-insulin-dependent diabetes mellitus patients.
Topics: Aged; Albuminuria; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fasting; Female; Homocysteine; Humans; Male; Methionine; Middle Aged | 1998 |
Plasma homocysteine and folate are related to arterial blood pressure in type 2 diabetes mellitus.
Topics: Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diabetes Mellitus, Type 2; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged | 1998 |
Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria.
Topics: Adult; Aged; Albuminuria; Cardiovascular Diseases; Denmark; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors; Survival Analysis | 1999 |
Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Aging; Creatinine; Cysteine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Folic Acid; Glomerular Filtration Rate; Homocysteine; Humans; Insulin; Middle Aged; Vitamin B 12 | 1999 |
Is plasma homocysteine related to albumin excretion rate in patients with diabetes mellitus?
Topics: Albuminuria; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Homocysteine; Humans | 1999 |
Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type 2 diabetes.
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Japan; Male; Middle Aged; Risk Factors | 1999 |
Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease.
Topics: Administration, Oral; Adult; Aged; Albuminuria; Analysis of Variance; Blood Pressure; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Fasting; Female; Folic Acid; Homocysteine; Humans; Male; Methionine; Middle Aged; Postmenopause; Premenopause; Pyridoxal Phosphate; Regression Analysis; Risk Factors; Vitamin B 12 | 1999 |
Implication of fibrate therapy for homocysteine.
Topics: Diabetes Mellitus, Type 2; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents | 1999 |
Factors influencing plasma homocysteine levels in type 2 diabetes.
Topics: Albuminuria; Blood Pressure; Cholesterol; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Homocysteine; Humans; Male; Reference Values; Regression Analysis; Triglycerides; Vitamins | 2000 |
Homocysteine and insulin levels in type 2 diabetic patients.
Topics: Diabetes Mellitus, Type 2; Homocysteine; Humans; Insulin; Insulin Resistance | 2000 |
Impaired glucose tolerance (IGT) is not associated with disturbed homocysteine metabolism.
Topics: Blood Glucose; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Fasting; Folic Acid; Homocysteine; Humans; Insulin; Male; Methionine; Middle Aged; Proinsulin; Risk Factors; Time Factors; Vitamin B 12 | 2000 |
Cardiovascular autonomic function is associated with (micro-)albuminuria in elderly Caucasian sujects with impaired glucose tolerance or type 2 diabetes: the Hoorn Study.
Topics: Aged; Albuminuria; Autonomic Nervous System; Blood Glucose; Blood Pressure; Creatinine; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Glucose Tolerance Test; Heart Rate; Homocysteine; Humans; Lipids; Middle Aged; Netherlands; Odds Ratio; Risk Factors; White People | 2000 |
Serum homocysteine is weakly associated with von Willebrand factor and soluble vascular cell adhesion molecule 1, but not with C-reactive protein in type 2 diabetic and non-diabetic subjects - The Hoorn Study.
Topics: Aged; C-Reactive Protein; Cardiovascular Diseases; Cell Adhesion Molecules; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors; von Willebrand Factor | 2000 |
The association between two common mutations C677T and A1298C in human methylenetetrahydrofolate reductase gene and the risk for diabetic nephropathy in type II diabetic patients.
Topics: Aged; Albuminuria; Alleles; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Folic Acid; Gene Frequency; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors | 2000 |
Homocysteine and endogenous markers of renal function in type 2 diabetic patients without coronary heart disease.
Topics: Albuminuria; Biomarkers; Blood Pressure; Coronary Disease; Creatinine; Cystatin C; Cystatins; Cysteine Proteinase Inhibitors; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Homocysteine; Humans; Kidney Function Tests; Male; Middle Aged | 2000 |
Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance.
Topics: Aged; Cohort Studies; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Folic Acid; Homeostasis; Homocysteine; Humans; Hyperhomocysteinemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Logistic Models; Male; Metabolic Clearance Rate; Metformin; Middle Aged; Vitamin B 12 | 2000 |
Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn study.
Topics: Age Factors; Aged; Albuminuria; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glucose Intolerance; Homocysteine; Humans; Least-Squares Analysis; Male; Middle Aged; Prospective Studies; Sex Factors | 2001 |
Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes.
Topics: Blood Glucose; Blood Pressure; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glucose Clamp Technique; Glycated Hemoglobin; Homocysteine; Humans; Infusions, Intravenous; Insulin; Insulin Resistance; Male; Middle Aged; Reference Values; Regression Analysis; Uric Acid | 2001 |
Relation between homocysteinaemia and diabetic neuropathy in patients with Type 2 diabetes mellitus.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Blood Pressure; Creatinine; Cystatin C; Cystatins; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Folic Acid; Glomerular Filtration Rate; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Pyridoxine; Vitamin B 12 | 2001 |
Homocysteine-induced inhibition of nitric oxide production in platelets: a study on healthy and diabetic subjects.
Topics: Adult; Blood Platelets; Chromatography, High Pressure Liquid; Cohort Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Male; Middle Aged; Nitric Oxide; Platelet Activation; Platelet Aggregation; Thrombin | 2001 |
The relationship among homocysteine, creatinine clearance, and albuminuria in patients with type 2 diabetes.
Topics: Aged; Albuminuria; Creatinine; Diabetes Mellitus, Type 2; Female; Folic Acid; Homocysteine; Humans; Male; Metabolic Clearance Rate; Middle Aged; Regression Analysis; Vitamin B 12 | 2001 |
[The association of methylenetetrahydrofolate reductase gene polymorphism with nephropathy in type 2 diabetes mellitus in Chinese].
Topics: Adult; Alleles; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Genetic Predisposition to Disease; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic | 2001 |
Total homocysteine and cognitive deterioration in people with type 2 diabetes.
Topics: Aged; Albuminuria; Cholesterol; Cognition; Cognition Disorders; Diabetes Mellitus, Type 2; Female; Folic Acid; Glycated Hemoglobin; Homocysteine; Humans; Lipoproteins; Male; Middle Aged; Triglycerides; Vitamin B 12 | 2002 |
Plasma homocysteine, methylenetetrahydrofolate reductase gene polymorphism and carotid intima-media thickness in Italian type 2 diabetic patients.
Topics: Aged; Carotid Arteries; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Genotype; Homocysteine; Humans; Italy; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Single Nucleotide; Prevalence; Risk Factors; Tunica Intima; Ultrasonography | 2002 |
Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies.
Topics: Aged; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Epidemiologic Studies; Female; Homocysteine; Humans; Male; Middle Aged; Regression Analysis; Risk Assessment | 2001 |
Plasma homocysteine is not increased in microalbuminuric patients with type 2 diabetes without clinical cardiovascular disease.
Topics: Aged; Albuminuria; Blood Glucose; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Homocysteine; Humans; Male; Middle Aged; Reference Values | 2002 |
Helicobacter pylori masks differences in homocysteine plasma levels between controls and type 2 diabetic patients.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Helicobacter Infections; Helicobacter pylori; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation | 2002 |
[The impact of plasma homocysteine level on development of retinopathy in type 2 diabetes mellitus].
Topics: Adult; Aged; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Severity of Illness Index | 2002 |
Hyperhomocysteinemia and impaired vasomotor function in type 2 diabetes mellitus.
Topics: Adult; Brachial Artery; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Factors; Ultrasonography; Vasodilation | 2002 |
Homocysteine, folate, methylene tetrahydrofolate reductase genotype and vascular morbidity in diabetic subjects.
Topics: Adult; Aged; Analysis of Variance; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Erythrocytes; Female; Folic Acid; Genotype; Homocysteine; Humans; Logistic Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Stroke | 2002 |